data_6fbl_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6fbl _Structure_validation_residue.Date_analyzed 2019-01-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.757 0.313 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.448 HD11 ' HG ' ' A' ' 69' ' ' CYS . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.418 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.418 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.448 ' HG ' HD11 ' A' ' 13' ' ' ILE . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.228 -0.052 0 CA-C-O 120.765 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HG ' ' A' ' 69' ' ' CYS . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HG ' HD13 ' A' ' 13' ' ' ILE . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' ' HG ' ' A' ' 69' ' ' CYS . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HG ' ' HG3' ' A' ' 11' ' ' GLU . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 81' ' ' GLN . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 79' ' ' LEU . 67.5 mm-40 . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.802 0.334 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 HD11 ' HG ' ' A' ' 69' ' ' CYS . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.417 ' HG ' HD11 ' A' ' 13' ' ' ILE . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.447 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.709 0.29 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.231 0.128 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.43 HD12 ' HG ' ' A' ' 69' ' ' CYS . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.416 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.43 ' HG ' HD12 ' A' ' 13' ' ' ILE . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.977 0.418 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLN . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' LEU . 75.8 mm-40 . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.508 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.508 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.664 0.268 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.413 HD22 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG1' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.456 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.505 HD13 ' HG ' ' A' ' 69' ' ' CYS . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.505 ' HG ' HD13 ' A' ' 13' ' ' ILE . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.491 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.469 HD22 ' CG2' ' A' ' 32' ' ' VAL . 20.2 p30 -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG2' HD22 ' A' ' 28' ' ' ASN . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.444 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 81' ' ' GLN . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 79' ' ' LEU . 73.6 mm-40 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.58 0.229 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HB3' ' HZ1' ' A' ' 14' ' ' LYS . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.628 -0.138 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.7 87.14 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.941 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -66.59 153.49 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.559 0.679 . . . . 0.0 111.574 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -76.63 -9.76 58.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -154.7 -27.25 0.12 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.34 147.35 40.18 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.5 0.591 . . . . 0.0 110.632 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -137.77 163.07 32.26 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -79.06 -1.27 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.201 0.6 . . . . 0.0 112.077 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.56 144.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 C-N-CA 123.056 0.542 . . . . 0.0 111.165 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.91 156.58 17.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.915 0.886 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 HD11 ' HG ' ' A' ' 69' ' ' CYS . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.418 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.418 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.448 ' HG ' HD11 ' A' ' 13' ' ' ILE . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 50.96 19.13 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.9 t -156.85 5.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -80.35 21.84 0.59 Allowed 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.629 -0.67 . . . . 0.0 111.718 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -66.65 -13.15 60.83 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.35 0.66 . . . . 0.0 111.889 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -72.0 5.32 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.552 178.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.2 0.048 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.36 -179.7 46.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -66.36 150.38 48.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.715 0.258 . . . . 0.0 111.176 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -65.23 -5.63 7.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.112 0.565 . . . . 0.0 111.79 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.5 ttm -76.9 -16.67 59.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.068 0.547 . . . . 0.0 111.095 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -135.1 11.57 3.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -139.64 158.5 44.0 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.8 m -78.61 1.23 23.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -69.28 147.79 11.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.894 0.478 . . . . 0.0 111.154 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m -139.05 159.0 29.6 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 C-N-CA 123.062 0.545 . . . . 0.0 111.27 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.437 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 52.26 18.38 0.88 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 t -84.71 7.65 19.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.815 0.846 . . . . 0.0 112.149 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -62.0 147.86 45.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.914 -0.491 . . . . 0.0 111.613 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -82.62 15.72 2.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.423 0.689 . . . . 0.0 112.516 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.256 53.1 m-20 61.19 28.22 17.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.093 178.13 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.533 0.206 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.89 -179.51 48.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -66.97 154.58 40.79 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.049 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -73.98 165.56 24.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.831 0.453 . . . . 0.0 110.9 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 73.6 mtm -80.49 3.91 20.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.289 0.636 . . . . 0.0 112.485 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -146.4 23.61 1.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 150.98 19.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.0 t -71.24 -15.52 62.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.698 0.399 . . . . 0.0 110.814 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.67 138.16 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m -147.01 156.71 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HG ' ' A' ' 69' ' ' CYS . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.403 ' HG ' HD13 ' A' ' 13' ' ' ILE . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 52.07 18.79 0.89 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t -162.25 -15.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.4 146.96 52.74 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.779 -0.576 . . . . 0.0 109.694 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -149.69 0.32 0.48 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.32 3.76 23.01 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.178 -1.391 . . . . 0.0 110.718 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.507 0.194 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.56 -177.89 44.98 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -67.12 147.88 52.55 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -84.81 0.52 50.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.944 0.498 . . . . 0.0 111.582 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.8 ttp 57.46 18.36 4.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.451 1.101 . . . . 0.0 111.956 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.63 4.09 19.78 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.132 0.573 . . . . 0.0 111.659 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 153.1 31.01 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.8 p -73.78 -10.6 59.84 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.54 147.18 11.6 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.8 156.23 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' ' HG ' ' A' ' 69' ' ' CYS . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.451 ' HG ' ' HG3' ' A' ' 11' ' ' GLU . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 81' ' ' GLN . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 79' ' ' LEU . 67.5 mm-40 50.72 24.73 1.81 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.4 p -73.97 6.83 3.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.322 1.049 . . . . 0.0 113.59 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -64.43 160.8 18.35 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.421 0.688 . . . . 0.0 111.529 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -72.42 -8.73 56.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.654 0.382 . . . . 0.0 111.838 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -74.66 70.25 1.82 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.588 0.755 . . . . 0.0 111.781 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.043 -1.456 . . . . 0.0 110.884 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.84 48.78 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -157.35 157.23 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.885 0.474 . . . . 0.0 110.76 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -72.22 -4.85 31.85 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.993 0.517 . . . . 0.0 111.768 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.26 -1.99 23.01 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 112.144 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -151.09 149.63 29.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.002 0.521 . . . . 0.0 110.269 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.38 162.26 28.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 98.5 m -129.56 6.37 5.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.592 0.757 . . . . 0.0 111.338 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.75 147.81 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.125 0.57 . . . . 0.0 111.609 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m -145.34 155.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.874 0.87 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.42 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? 50.47 29.53 4.03 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -65.77 -19.52 65.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.748 0.419 . . . . 0.0 111.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -69.84 132.03 45.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.079 -0.388 . . . . 0.0 110.547 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -87.09 -12.61 46.67 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -90.68 4.5 51.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.38 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.57 0.224 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.96 -179.88 46.79 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -157.08 169.96 23.6 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -68.05 -8.63 39.39 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.352 . . . . 0.0 111.669 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.3 mtp -80.92 -5.92 58.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.083 0.553 . . . . 0.0 111.311 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.59 145.83 55.17 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.025 0.53 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.7 167.67 19.37 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.0 t -131.66 23.59 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.24 144.95 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.923 0.489 . . . . 0.0 111.196 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.57 155.48 16.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.597 0.759 . . . . 0.0 109.556 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 HD11 ' HG ' ' A' ' 69' ' ' CYS . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.417 ' HG ' HD11 ' A' ' 13' ' ' ILE . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.447 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.447 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 49.79 21.64 0.7 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.9 p -76.97 7.48 4.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.41 0.684 . . . . 0.0 111.869 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -72.56 16.02 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 112.59 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -70.22 -13.63 62.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.087 0.555 . . . . 0.0 111.04 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.261 69.6 m-20 58.09 12.57 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.222 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.1 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.562 0.22 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.93 6.66 87.39 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -65.86 147.62 53.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.782 0.791 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -158.67 153.12 24.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.153 0.581 . . . . 0.0 110.222 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -9.34 48.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.619 0.368 . . . . 0.0 111.816 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -74.21 166.61 23.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.887 0.475 . . . . 0.0 110.943 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -64.03 160.46 17.95 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.9 m -119.0 -1.68 10.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.152 0.581 . . . . 0.0 111.545 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.79 147.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 122.772 0.429 . . . . 0.0 111.377 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m -142.21 153.27 18.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 56.96 11.8 1.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -78.11 -11.95 59.95 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.582 -0.699 . . . . 0.0 111.162 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.67 167.66 16.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.005 0.522 . . . . 0.0 111.58 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.1 21.47 5.16 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.107 0.963 . . . . 0.0 112.951 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -69.94 -11.58 60.98 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.461 -177.918 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 174.74 47.28 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -76.21 -9.68 58.82 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 111.93 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -72.39 152.99 41.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.919 0.488 . . . . 0.0 110.851 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 95.1 mmm -79.82 -6.49 57.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.72 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -154.59 151.62 29.06 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.697 0.799 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 157.66 31.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -82.2 1.35 36.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.35 0.66 . . . . 0.0 111.936 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.43 141.56 16.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 122.608 0.363 . . . . 0.0 111.779 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -144.86 153.99 14.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.466 0.707 . . . . 0.0 111.704 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 51.0 31.48 6.36 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.3 t -64.15 -19.18 65.12 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.99 -0.444 . . . . 0.0 110.994 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -155.71 141.62 18.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.835 0.854 . . . . 0.0 109.791 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -89.44 7.47 35.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.232 0.613 . . . . 0.0 112.04 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.258 38.7 m-20 59.91 18.28 7.34 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.534 1.133 . . . . 0.0 110.422 -178.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.719 0.295 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.56 179.64 44.35 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.2 t -154.89 158.67 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.499 0.72 . . . . 0.0 109.604 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p80 46.29 45.0 13.03 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.455 1.102 . . . . 0.0 112.139 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 59.52 23.02 11.64 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.238 1.015 . . . . 0.0 113.381 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 54.9 25.42 6.74 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.176 0.99 . . . . 0.0 113.059 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 p -66.3 159.75 25.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.47 -8.39 58.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.09 148.94 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.18 159.36 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.819 0.848 . . . . 0.0 109.316 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? 53.93 20.9 2.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -142.81 -11.15 0.78 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.33 159.41 31.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.646 -0.659 . . . . 0.0 110.424 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -147.92 -22.39 0.36 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -78.47 65.49 3.79 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.754 -0.592 . . . . 0.0 111.756 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.845 179.531 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.7 -178.76 48.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -71.64 -8.62 55.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.901 0.48 . . . . 0.0 112.256 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.01 158.77 43.5 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.847 0.859 . . . . 0.0 109.995 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.64 -16.43 62.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.509 0.324 . . . . 0.0 111.037 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -151.51 138.61 19.18 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.622 0.769 . . . . 0.0 110.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.01 155.67 40.55 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.6 p -69.57 -9.05 52.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.43 146.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -148.05 158.12 8.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.857 0.863 . . . . 0.0 108.982 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.43 HD12 ' HG ' ' A' ' 69' ' ' CYS . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.416 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.416 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.43 ' HG ' HD12 ' A' ' 13' ' ' ILE . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.56 13.65 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -156.66 27.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.543 -0.723 . . . . 0.0 111.04 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.49 143.87 48.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.78 -0.575 . . . . 0.0 111.326 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -156.74 -30.12 0.09 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.963 0.505 . . . . 0.0 111.682 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -150.77 4.1 0.48 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.543 -1.218 . . . . 0.0 111.227 -177.621 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.13 -179.32 48.02 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -156.66 172.49 18.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.562 0.745 . . . . 0.0 110.05 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.15 -1.86 28.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.6 mtm 54.99 21.41 3.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.258 1.023 . . . . 0.0 112.774 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -154.4 150.86 28.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.113 0.565 . . . . 0.0 109.938 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.52 155.65 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.08 60.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.4 147.19 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m -143.51 159.07 16.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.79 0.836 . . . . 0.0 110.408 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 54.92 12.36 0.59 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.4 t -95.27 -24.08 16.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.443 0.697 . . . . 0.0 110.33 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -82.55 11.11 6.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.937 0.895 . . . . 0.0 111.079 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.91 -5.48 17.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -137.33 4.1 2.64 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.539 -1.219 . . . . 0.0 110.344 175.68 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.307 0.098 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -178.65 42.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -150.26 8.0 0.61 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.765 0.426 . . . . 0.0 111.348 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -142.34 154.26 44.52 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.39 0.676 . . . . 0.0 110.511 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -81.34 0.31 37.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.136 0.574 . . . . 0.0 112.302 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 54.8 28.07 9.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.323 1.049 . . . . 0.0 113.543 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.09 157.82 21.22 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.5 t -83.27 -0.38 49.32 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.962 0.505 . . . . 0.0 110.41 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -66.1 143.65 15.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 O-C-N 121.762 -0.586 . . . . 0.0 111.413 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 158.18 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 81' ' ' GLN . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 79' ' ' LEU . 75.8 mm-40 52.02 19.71 1.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.6 p -74.12 -8.44 56.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.241 0.616 . . . . 0.0 111.729 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -144.57 156.96 44.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.946 0.898 . . . . 0.0 110.447 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -140.35 1.35 1.77 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.09 0.556 . . . . 0.0 111.215 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -87.24 12.35 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 mttp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.985 -176.252 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.59 48.82 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -155.93 155.66 33.22 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.129 0.572 . . . . 0.0 110.571 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -68.89 -9.53 52.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.665 0.386 . . . . 0.0 111.381 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.0 tpp -73.72 -18.15 61.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.201 0.6 . . . . 0.0 110.928 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.02 146.91 53.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.36 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.58 166.12 15.56 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.6 t -139.45 10.47 2.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.721 0.808 . . . . 0.0 109.049 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 147.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.053 0.541 . . . . 0.0 111.727 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.1 158.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 49.62 29.31 2.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 94.0 p -68.52 1.21 3.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.556 0.743 . . . . 0.0 112.715 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -140.22 162.58 34.92 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.926 0.89 . . . . 0.0 109.566 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 55.08 30.31 14.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.19 0.596 . . . . 0.0 111.911 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -71.04 -0.58 9.76 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.548 -1.215 . . . . 0.0 110.026 -179.357 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.786 0.327 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 10.1 86.45 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.842 -0.421 . . . . 0.0 112.839 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 t -66.38 161.73 21.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.644 0.722 . . . . 0.0 111.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -61.58 -13.65 23.51 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.906 0.882 . . . . 0.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.8 mtm -84.06 -2.92 57.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.604 0.362 . . . . 0.0 111.808 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.37 18.01 3.68 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.125 0.57 . . . . 0.0 112.49 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 152.47 21.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 p -70.18 -6.7 36.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.82 145.9 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 122.762 0.425 . . . . 0.0 110.001 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.15 153.19 22.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.405 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.508 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.508 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 82' ' ' SER . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.13 4.19 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' MET . 92.5 p -89.03 -15.72 33.38 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.425 0.69 . . . . 0.0 110.523 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -90.13 157.75 17.6 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.305 0.642 . . . . 0.0 111.507 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.38 14.92 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.367 0.667 . . . . 0.0 110.791 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -148.49 39.32 0.89 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.592 -1.195 . . . . 0.0 110.984 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.299 0.095 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.84 179.13 48.54 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -145.43 163.02 35.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.582 0.753 . . . . 0.0 110.552 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -69.98 158.72 35.09 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.162 0.506 . . . . 0.0 111.423 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 ttt -149.88 45.34 0.92 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.024 0.93 . . . . 0.0 109.105 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.55 21.68 7.35 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.131 0.972 . . . . 0.0 112.237 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.54 152.43 30.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.5 m -74.05 -7.31 52.01 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -71.19 143.61 14.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.065 0.546 . . . . 0.0 111.606 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.44 159.92 12.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.851 0.86 . . . . 0.0 110.354 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.413 HD22 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.413 ' CG1' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 52.8 23.97 3.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.6 p -147.69 -9.7 0.41 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -77.77 152.34 33.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.791 0.723 . . . . 0.0 110.72 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.59 -13.09 60.0 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -86.36 2.27 48.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.206 178.852 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.43 160.24 24.95 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -70.2 151.12 45.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -141.58 156.89 45.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.085 0.954 . . . . 0.0 110.399 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.4 ttt -73.45 -22.9 60.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.617 0.367 . . . . 0.0 111.32 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -74.07 158.73 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.827 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.68 162.93 22.6 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.9 m -128.42 6.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.596 0.758 . . . . 0.0 110.853 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.88 149.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.958 0.503 . . . . 0.0 111.894 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.83 156.78 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 123.77 0.828 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 53.41 24.03 3.71 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 m -132.79 -1.28 3.39 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 111.406 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -130.22 10.24 5.32 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.884 0.874 . . . . 0.0 111.592 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -65.37 -17.95 64.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.609 0.364 . . . . 0.0 111.591 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -79.61 1.42 26.19 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.447 -1.264 . . . . 0.0 110.893 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.62 -15.37 80.62 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.8 p -77.66 -6.47 53.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.643 0.722 . . . . 0.0 111.452 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 m80 58.91 170.66 0.06 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.834 1.254 . . . . 0.0 113.2 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -73.09 -8.5 56.02 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.309 0.644 . . . . 0.0 111.19 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -154.69 147.97 24.94 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.31 0.644 . . . . 0.0 109.587 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 139.79 58.06 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.2 p -78.1 -3.64 43.34 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.89 148.65 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.65 153.47 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.159 0.584 . . . . 0.0 110.631 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.401 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.456 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.401 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.456 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 55.82 13.21 1.02 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.0 p -158.45 2.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -68.89 -0.22 5.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.99 0.814 . . . . 0.0 111.832 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.36 -14.12 62.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.037 -0.414 . . . . 0.0 110.638 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.278 64.3 m-20 57.2 10.8 0.92 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.068 178.374 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.86 178.43 50.9 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.6 p -157.81 168.03 28.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.478 0.711 . . . . 0.0 110.475 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -153.16 161.92 41.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.99 0.516 . . . . 0.0 109.937 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.52 -9.81 58.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.89 0.476 . . . . 0.0 112.257 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.79 159.43 42.52 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.057 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.66 156.64 37.79 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.0 m -84.19 2.48 39.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.238 0.615 . . . . 0.0 111.657 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.7 146.77 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.132 0.573 . . . . 0.0 111.832 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m -142.9 159.71 18.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.527 0.731 . . . . 0.0 110.876 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.505 HD13 ' HG ' ' A' ' 69' ' ' CYS . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.417 ' CZ3' ' HD3' ' A' ' 58' ' ' PRO . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' HD3' ' CZ3' ' A' ' 16' ' ' TRP . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.505 ' HG ' HD13 ' A' ' 13' ' ' ILE . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.491 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.491 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 51.29 24.93 2.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -147.45 17.37 1.17 Allowed 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.886 -0.509 . . . . 0.0 111.284 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -61.43 150.38 35.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.785 0.434 . . . . 0.0 111.257 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.32 -5.24 38.33 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.346 0.658 . . . . 0.0 111.867 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.38 5.49 1.74 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.393 -179.386 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.55 0.214 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.91 42.31 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 t -156.9 153.7 28.58 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.827 0.451 . . . . 0.0 110.527 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -68.68 -9.94 53.3 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.778 0.431 . . . . 0.0 111.163 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.1 ttp -72.6 -10.84 60.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.281 0.632 . . . . 0.0 111.347 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 52.76 48.83 21.63 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.814 0.845 . . . . 0.0 110.431 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.76 146.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -75.41 -13.89 60.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.005 0.522 . . . . 0.0 111.363 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.5 138.19 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.087 -0.383 . . . . 0.0 111.114 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m -151.23 163.28 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.624 1.17 . . . . 0.0 108.644 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.469 HD22 ' CG2' ' A' ' 32' ' ' VAL . 20.2 p30 -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' CG2' HD22 ' A' ' 28' ' ' ASN . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.444 ' HG ' ' CB ' ' A' ' 72' ' ' ALA . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.444 ' CB ' ' HG ' ' A' ' 42' ' ' CYS . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 81' ' ' GLN . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 79' ' ' LEU . 73.6 mm-40 52.63 17.86 0.89 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.4 t -73.24 -14.24 61.29 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.903 -0.498 . . . . 0.0 111.199 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -76.05 -1.49 26.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.042 0.537 . . . . 0.0 112.226 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -75.83 -10.41 59.4 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.19 14.07 0.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.691 0.797 . . . . 0.0 112.458 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.411 0.148 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.11 85.54 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.965 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.1 p -77.25 -10.15 59.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.43 1.115 . . . . 0.0 111.417 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -72.89 163.05 28.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.072 0.549 . . . . 0.0 110.753 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.9 ttm -70.07 -23.28 63.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.705 0.402 . . . . 0.0 111.233 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.19 141.54 50.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.855 0.462 . . . . 0.0 109.947 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.24 154.63 41.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -87.03 3.7 44.93 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.102 0.561 . . . . 0.0 111.69 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.28 140.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.165 0.586 . . . . 0.0 112.347 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m -145.36 155.47 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.67 0.788 . . . . 0.0 111.303 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HB3' ' HZ1' ' A' ' 14' ' ' LYS . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 51.36 15.98 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -156.11 8.59 0.23 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.698 0.399 . . . . 0.0 111.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -148.37 18.97 1.07 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.791 -0.568 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.75 -9.94 56.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.759 0.424 . . . . 0.0 111.409 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -76.58 2.27 14.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.371 -1.299 . . . . 0.0 109.836 179.554 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.757 0.313 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.425 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.228 -0.052 0 CA-C-O 120.765 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.802 0.334 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.45 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.709 0.29 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.231 0.128 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.977 0.418 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 HG23 ' A' ' 32' ' ' VAL . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 HD21 ' A' ' 28' ' ' ASN . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.664 0.268 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.501 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.58 0.229 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.628 -0.138 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.7 87.14 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.941 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -66.59 153.49 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.559 0.679 . . . . 0.0 111.574 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -76.63 -9.76 58.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -154.7 -27.25 0.12 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.34 147.35 40.18 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.5 0.591 . . . . 0.0 110.632 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -137.77 163.07 32.26 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -79.06 -1.27 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.201 0.6 . . . . 0.0 112.077 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.56 144.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 C-N-CA 123.056 0.542 . . . . 0.0 111.165 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.91 156.58 17.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.915 0.886 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.425 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 50.96 19.13 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.9 t -156.85 5.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -80.35 21.84 0.59 Allowed 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.629 -0.67 . . . . 0.0 111.718 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -66.65 -13.15 60.83 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.35 0.66 . . . . 0.0 111.889 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -72.0 5.32 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.552 178.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.2 0.048 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.36 -179.7 46.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -66.36 150.38 48.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.715 0.258 . . . . 0.0 111.176 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -65.23 -5.63 7.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.112 0.565 . . . . 0.0 111.79 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.5 ttm -76.9 -16.67 59.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.068 0.547 . . . . 0.0 111.095 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -135.1 11.57 3.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -139.64 158.5 44.0 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.8 m -78.61 1.23 23.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -69.28 147.79 11.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.894 0.478 . . . . 0.0 111.154 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m -139.05 159.0 29.6 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 C-N-CA 123.062 0.545 . . . . 0.0 111.27 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 52.26 18.38 0.88 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 t -84.71 7.65 19.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.815 0.846 . . . . 0.0 112.149 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -62.0 147.86 45.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.914 -0.491 . . . . 0.0 111.613 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -82.62 15.72 2.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.423 0.689 . . . . 0.0 112.516 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.256 53.1 m-20 61.19 28.22 17.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.093 178.13 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.533 0.206 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.89 -179.51 48.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -66.97 154.58 40.79 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.049 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -73.98 165.56 24.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.831 0.453 . . . . 0.0 110.9 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 73.6 mtm -80.49 3.91 20.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.289 0.636 . . . . 0.0 112.485 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -146.4 23.61 1.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 150.98 19.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.0 t -71.24 -15.52 62.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.698 0.399 . . . . 0.0 110.814 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.67 138.16 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m -147.01 156.71 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 52.07 18.79 0.89 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t -162.25 -15.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.4 146.96 52.74 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.779 -0.576 . . . . 0.0 109.694 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -149.69 0.32 0.48 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.32 3.76 23.01 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.178 -1.391 . . . . 0.0 110.718 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.507 0.194 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.56 -177.89 44.98 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -67.12 147.88 52.55 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -84.81 0.52 50.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.944 0.498 . . . . 0.0 111.582 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.8 ttp 57.46 18.36 4.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.451 1.101 . . . . 0.0 111.956 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.63 4.09 19.78 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.132 0.573 . . . . 0.0 111.659 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 153.1 31.01 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.8 p -73.78 -10.6 59.84 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.54 147.18 11.6 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.8 156.23 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 50.72 24.73 1.81 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.4 p -73.97 6.83 3.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.322 1.049 . . . . 0.0 113.59 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -64.43 160.8 18.35 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.421 0.688 . . . . 0.0 111.529 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -72.42 -8.73 56.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.654 0.382 . . . . 0.0 111.838 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -74.66 70.25 1.82 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.588 0.755 . . . . 0.0 111.781 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.043 -1.456 . . . . 0.0 110.884 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.84 48.78 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -157.35 157.23 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.885 0.474 . . . . 0.0 110.76 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -72.22 -4.85 31.85 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.993 0.517 . . . . 0.0 111.768 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.26 -1.99 23.01 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 112.144 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -151.09 149.63 29.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.002 0.521 . . . . 0.0 110.269 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.38 162.26 28.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 98.5 m -129.56 6.37 5.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.592 0.757 . . . . 0.0 111.338 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.75 147.81 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.125 0.57 . . . . 0.0 111.609 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m -145.34 155.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.874 0.87 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? 50.47 29.53 4.03 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -65.77 -19.52 65.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.748 0.419 . . . . 0.0 111.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -69.84 132.03 45.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.079 -0.388 . . . . 0.0 110.547 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -87.09 -12.61 46.67 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -90.68 4.5 51.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.38 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.57 0.224 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.96 -179.88 46.79 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -157.08 169.96 23.6 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -68.05 -8.63 39.39 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.352 . . . . 0.0 111.669 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.3 mtp -80.92 -5.92 58.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.083 0.553 . . . . 0.0 111.311 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.59 145.83 55.17 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.025 0.53 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.7 167.67 19.37 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.0 t -131.66 23.59 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.24 144.95 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.923 0.489 . . . . 0.0 111.196 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.57 155.48 16.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.597 0.759 . . . . 0.0 109.556 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.45 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 49.79 21.64 0.7 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.9 p -76.97 7.48 4.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.41 0.684 . . . . 0.0 111.869 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -72.56 16.02 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 112.59 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -70.22 -13.63 62.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.087 0.555 . . . . 0.0 111.04 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.261 69.6 m-20 58.09 12.57 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.222 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.1 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.562 0.22 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.93 6.66 87.39 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -65.86 147.62 53.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.782 0.791 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -158.67 153.12 24.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.153 0.581 . . . . 0.0 110.222 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -9.34 48.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.619 0.368 . . . . 0.0 111.816 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -74.21 166.61 23.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.887 0.475 . . . . 0.0 110.943 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -64.03 160.46 17.95 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.9 m -119.0 -1.68 10.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.152 0.581 . . . . 0.0 111.545 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.79 147.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 122.772 0.429 . . . . 0.0 111.377 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m -142.21 153.27 18.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 56.96 11.8 1.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -78.11 -11.95 59.95 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.582 -0.699 . . . . 0.0 111.162 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.67 167.66 16.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.005 0.522 . . . . 0.0 111.58 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.1 21.47 5.16 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.107 0.963 . . . . 0.0 112.951 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -69.94 -11.58 60.98 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.461 -177.918 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 174.74 47.28 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -76.21 -9.68 58.82 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 111.93 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -72.39 152.99 41.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.919 0.488 . . . . 0.0 110.851 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 95.1 mmm -79.82 -6.49 57.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.72 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -154.59 151.62 29.06 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.697 0.799 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 157.66 31.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -82.2 1.35 36.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.35 0.66 . . . . 0.0 111.936 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.43 141.56 16.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 122.608 0.363 . . . . 0.0 111.779 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -144.86 153.99 14.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.466 0.707 . . . . 0.0 111.704 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 51.0 31.48 6.36 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.3 t -64.15 -19.18 65.12 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.99 -0.444 . . . . 0.0 110.994 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -155.71 141.62 18.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.835 0.854 . . . . 0.0 109.791 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -89.44 7.47 35.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.232 0.613 . . . . 0.0 112.04 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.258 38.7 m-20 59.91 18.28 7.34 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.534 1.133 . . . . 0.0 110.422 -178.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.719 0.295 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.56 179.64 44.35 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.2 t -154.89 158.67 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.499 0.72 . . . . 0.0 109.604 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p80 46.29 45.0 13.03 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.455 1.102 . . . . 0.0 112.139 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 59.52 23.02 11.64 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.238 1.015 . . . . 0.0 113.381 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 54.9 25.42 6.74 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.176 0.99 . . . . 0.0 113.059 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 p -66.3 159.75 25.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.47 -8.39 58.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.09 148.94 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.18 159.36 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.819 0.848 . . . . 0.0 109.316 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? 53.93 20.9 2.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -142.81 -11.15 0.78 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.33 159.41 31.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.646 -0.659 . . . . 0.0 110.424 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -147.92 -22.39 0.36 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -78.47 65.49 3.79 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.754 -0.592 . . . . 0.0 111.756 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.845 179.531 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.7 -178.76 48.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -71.64 -8.62 55.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.901 0.48 . . . . 0.0 112.256 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.01 158.77 43.5 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.847 0.859 . . . . 0.0 109.995 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.64 -16.43 62.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.509 0.324 . . . . 0.0 111.037 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -151.51 138.61 19.18 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.622 0.769 . . . . 0.0 110.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.01 155.67 40.55 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.6 p -69.57 -9.05 52.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.43 146.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -148.05 158.12 8.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.857 0.863 . . . . 0.0 108.982 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.56 13.65 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -156.66 27.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.543 -0.723 . . . . 0.0 111.04 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.49 143.87 48.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.78 -0.575 . . . . 0.0 111.326 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -156.74 -30.12 0.09 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.963 0.505 . . . . 0.0 111.682 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -150.77 4.1 0.48 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.543 -1.218 . . . . 0.0 111.227 -177.621 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.13 -179.32 48.02 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -156.66 172.49 18.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.562 0.745 . . . . 0.0 110.05 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.15 -1.86 28.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.6 mtm 54.99 21.41 3.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.258 1.023 . . . . 0.0 112.774 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -154.4 150.86 28.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.113 0.565 . . . . 0.0 109.938 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.52 155.65 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.08 60.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.4 147.19 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m -143.51 159.07 16.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.79 0.836 . . . . 0.0 110.408 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 HG23 ' A' ' 32' ' ' VAL . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 HD21 ' A' ' 28' ' ' ASN . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 54.92 12.36 0.59 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.4 t -95.27 -24.08 16.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.443 0.697 . . . . 0.0 110.33 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -82.55 11.11 6.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.937 0.895 . . . . 0.0 111.079 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.91 -5.48 17.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -137.33 4.1 2.64 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.539 -1.219 . . . . 0.0 110.344 175.68 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.307 0.098 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -178.65 42.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -150.26 8.0 0.61 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.765 0.426 . . . . 0.0 111.348 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -142.34 154.26 44.52 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.39 0.676 . . . . 0.0 110.511 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -81.34 0.31 37.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.136 0.574 . . . . 0.0 112.302 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 54.8 28.07 9.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.323 1.049 . . . . 0.0 113.543 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.09 157.82 21.22 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.5 t -83.27 -0.38 49.32 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.962 0.505 . . . . 0.0 110.41 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -66.1 143.65 15.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 O-C-N 121.762 -0.586 . . . . 0.0 111.413 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 158.18 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 52.02 19.71 1.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.6 p -74.12 -8.44 56.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.241 0.616 . . . . 0.0 111.729 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -144.57 156.96 44.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.946 0.898 . . . . 0.0 110.447 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -140.35 1.35 1.77 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.09 0.556 . . . . 0.0 111.215 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -87.24 12.35 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 mttp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.985 -176.252 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.59 48.82 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -155.93 155.66 33.22 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.129 0.572 . . . . 0.0 110.571 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -68.89 -9.53 52.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.665 0.386 . . . . 0.0 111.381 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.0 tpp -73.72 -18.15 61.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.201 0.6 . . . . 0.0 110.928 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.02 146.91 53.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.36 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.58 166.12 15.56 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.6 t -139.45 10.47 2.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.721 0.808 . . . . 0.0 109.049 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 147.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.053 0.541 . . . . 0.0 111.727 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.1 158.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 49.62 29.31 2.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 94.0 p -68.52 1.21 3.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.556 0.743 . . . . 0.0 112.715 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -140.22 162.58 34.92 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.926 0.89 . . . . 0.0 109.566 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 55.08 30.31 14.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.19 0.596 . . . . 0.0 111.911 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -71.04 -0.58 9.76 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.548 -1.215 . . . . 0.0 110.026 -179.357 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.786 0.327 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 10.1 86.45 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.842 -0.421 . . . . 0.0 112.839 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 t -66.38 161.73 21.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.644 0.722 . . . . 0.0 111.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -61.58 -13.65 23.51 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.906 0.882 . . . . 0.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.8 mtm -84.06 -2.92 57.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.604 0.362 . . . . 0.0 111.808 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.37 18.01 3.68 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.125 0.57 . . . . 0.0 112.49 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 152.47 21.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 p -70.18 -6.7 36.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.82 145.9 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 122.762 0.425 . . . . 0.0 110.001 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.15 153.19 22.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.13 4.19 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 92.5 p -89.03 -15.72 33.38 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.425 0.69 . . . . 0.0 110.523 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -90.13 157.75 17.6 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.305 0.642 . . . . 0.0 111.507 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.38 14.92 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.367 0.667 . . . . 0.0 110.791 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -148.49 39.32 0.89 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.592 -1.195 . . . . 0.0 110.984 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.299 0.095 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.84 179.13 48.54 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -145.43 163.02 35.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.582 0.753 . . . . 0.0 110.552 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -69.98 158.72 35.09 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.162 0.506 . . . . 0.0 111.423 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 ttt -149.88 45.34 0.92 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.024 0.93 . . . . 0.0 109.105 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.55 21.68 7.35 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.131 0.972 . . . . 0.0 112.237 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.54 152.43 30.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.5 m -74.05 -7.31 52.01 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -71.19 143.61 14.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.065 0.546 . . . . 0.0 111.606 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.44 159.92 12.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.851 0.86 . . . . 0.0 110.354 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 52.8 23.97 3.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.6 p -147.69 -9.7 0.41 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -77.77 152.34 33.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.791 0.723 . . . . 0.0 110.72 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.59 -13.09 60.0 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -86.36 2.27 48.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.206 178.852 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.43 160.24 24.95 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -70.2 151.12 45.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -141.58 156.89 45.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.085 0.954 . . . . 0.0 110.399 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.4 ttt -73.45 -22.9 60.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.617 0.367 . . . . 0.0 111.32 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -74.07 158.73 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.827 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.68 162.93 22.6 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.9 m -128.42 6.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.596 0.758 . . . . 0.0 110.853 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.88 149.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.958 0.503 . . . . 0.0 111.894 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.83 156.78 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 123.77 0.828 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 53.41 24.03 3.71 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 m -132.79 -1.28 3.39 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 111.406 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -130.22 10.24 5.32 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.884 0.874 . . . . 0.0 111.592 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -65.37 -17.95 64.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.609 0.364 . . . . 0.0 111.591 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -79.61 1.42 26.19 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.447 -1.264 . . . . 0.0 110.893 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.62 -15.37 80.62 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.8 p -77.66 -6.47 53.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.643 0.722 . . . . 0.0 111.452 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 m80 58.91 170.66 0.06 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.834 1.254 . . . . 0.0 113.2 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -73.09 -8.5 56.02 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.309 0.644 . . . . 0.0 111.19 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -154.69 147.97 24.94 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.31 0.644 . . . . 0.0 109.587 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 139.79 58.06 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.2 p -78.1 -3.64 43.34 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.89 148.65 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.65 153.47 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.159 0.584 . . . . 0.0 110.631 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 55.82 13.21 1.02 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.0 p -158.45 2.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -68.89 -0.22 5.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.99 0.814 . . . . 0.0 111.832 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.36 -14.12 62.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.037 -0.414 . . . . 0.0 110.638 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.278 64.3 m-20 57.2 10.8 0.92 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.068 178.374 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.86 178.43 50.9 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.6 p -157.81 168.03 28.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.478 0.711 . . . . 0.0 110.475 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -153.16 161.92 41.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.99 0.516 . . . . 0.0 109.937 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.52 -9.81 58.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.89 0.476 . . . . 0.0 112.257 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.79 159.43 42.52 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.057 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.66 156.64 37.79 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.0 m -84.19 2.48 39.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.238 0.615 . . . . 0.0 111.657 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.7 146.77 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.132 0.573 . . . . 0.0 111.832 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m -142.9 159.71 18.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.527 0.731 . . . . 0.0 110.876 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.501 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 51.29 24.93 2.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -147.45 17.37 1.17 Allowed 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.886 -0.509 . . . . 0.0 111.284 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -61.43 150.38 35.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.785 0.434 . . . . 0.0 111.257 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.32 -5.24 38.33 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.346 0.658 . . . . 0.0 111.867 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.38 5.49 1.74 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.393 -179.386 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.55 0.214 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.91 42.31 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 t -156.9 153.7 28.58 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.827 0.451 . . . . 0.0 110.527 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -68.68 -9.94 53.3 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.778 0.431 . . . . 0.0 111.163 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.1 ttp -72.6 -10.84 60.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.281 0.632 . . . . 0.0 111.347 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 52.76 48.83 21.63 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.814 0.845 . . . . 0.0 110.431 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.76 146.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -75.41 -13.89 60.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.005 0.522 . . . . 0.0 111.363 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.5 138.19 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.087 -0.383 . . . . 0.0 111.114 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m -151.23 163.28 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.624 1.17 . . . . 0.0 108.644 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.498 HD21 HG23 ' A' ' 32' ' ' VAL . 20.2 p30 -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 28' ' ' ASN . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 52.63 17.86 0.89 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.4 t -73.24 -14.24 61.29 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.903 -0.498 . . . . 0.0 111.199 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -76.05 -1.49 26.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.042 0.537 . . . . 0.0 112.226 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -75.83 -10.41 59.4 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.19 14.07 0.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.691 0.797 . . . . 0.0 112.458 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.411 0.148 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.11 85.54 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.965 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.1 p -77.25 -10.15 59.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.43 1.115 . . . . 0.0 111.417 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -72.89 163.05 28.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.072 0.549 . . . . 0.0 110.753 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.9 ttm -70.07 -23.28 63.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.705 0.402 . . . . 0.0 111.233 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.19 141.54 50.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.855 0.462 . . . . 0.0 109.947 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.24 154.63 41.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -87.03 3.7 44.93 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.102 0.561 . . . . 0.0 111.69 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.28 140.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.165 0.586 . . . . 0.0 112.347 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m -145.36 155.47 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.67 0.788 . . . . 0.0 111.303 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 51.36 15.98 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -156.11 8.59 0.23 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.698 0.399 . . . . 0.0 111.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -148.37 18.97 1.07 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.791 -0.568 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.75 -9.94 56.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.759 0.424 . . . . 0.0 111.409 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -76.58 2.27 14.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.371 -1.299 . . . . 0.0 109.836 179.554 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.757 0.313 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.425 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 C--O 1.228 -0.052 0 CA-C-O 120.765 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.802 0.334 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.45 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 . . . . . 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.709 0.29 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 . . . . . 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.457 -0.108 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.231 0.128 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 . . . . . 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.977 0.418 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 HG23 ' A' ' 32' ' ' VAL . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 HD21 ' A' ' 28' ' ' ASN . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 CA--C 1.527 0.08 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.664 0.268 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.306 0.574 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 . . . . . 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.501 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.233 0.19 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.498 HD21 HG23 ' A' ' 32' ' ' VAL . 20.2 p30 -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 28' ' ' ASN . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.58 0.229 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 . . . . . 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 110.628 -0.138 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.57 8.7 87.14 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.931 -0.372 . . . . 0.0 112.941 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.8 t -66.59 153.49 42.92 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.559 0.679 . . . . 0.0 111.574 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -76.63 -9.76 58.9 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.0 ttt -154.7 -27.25 0.12 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -75.34 147.35 40.18 Favored 'General case' 0 N--CA 1.457 -0.083 0 CA-C-N 118.5 0.591 . . . . 0.0 110.632 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -137.77 163.07 32.26 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -79.06 -1.27 34.94 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.201 0.6 . . . . 0.0 112.077 177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.56 144.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 C-N-CA 123.056 0.542 . . . . 0.0 111.165 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.91 156.58 17.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 123.915 0.886 . . . . 0.0 110.811 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -82.88 160.7 22.09 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.25 0.62 . . . . 0.0 110.902 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -146.24 147.54 31.54 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -146.14 152.26 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 124.937 1.295 . . . . 0.0 107.949 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -144.63 139.46 28.07 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.425 ' NE2' ' H ' ' A' ' 16' ' ' TRP . 56.4 tp60 -155.03 158.58 39.34 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.584 0.354 . . . . 0.0 110.96 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.425 ' H ' ' NE2' ' A' ' 15' ' ' GLN . 61.9 m95 -104.95 148.04 27.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.828 0.851 . . . . 0.0 110.941 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.47 141.94 35.46 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 172.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -62.45 151.52 82.45 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.787 2.325 . . . . 0.0 109.658 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.09 -19.3 65.62 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -173.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.9 t -68.19 -4.44 13.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -138.09 10.6 2.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.29 -24.63 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.18 -11.85 67.94 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -84.04 0.53 47.86 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.916 0.858 . . . . 0.0 110.862 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.2 mt -125.85 -34.21 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 C-N-CA 122.979 0.512 . . . . 0.0 110.797 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.3 mt -117.71 13.03 14.13 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.526 0.73 . . . . 0.0 112.2 -174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.2 -14.18 65.87 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.502 -0.61 . . . . 0.0 113.919 -172.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -157.17 94.51 1.41 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 118.045 0.922 . . . . 0.0 110.418 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.4 mtt85 51.4 23.39 1.75 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.556 0.742 . . . . 0.0 112.95 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.54 23.9 3.79 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.914 0.886 . . . . 0.0 112.438 -175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.49 -24.76 67.64 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.484 0.314 . . . . 0.0 111.275 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 99.4 t -74.15 -36.09 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -69.41 -40.87 77.06 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -67.76 -22.16 65.22 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 123.445 0.698 . . . . 0.0 111.332 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -76.27 -32.4 58.81 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 117.968 0.349 . . . . 0.0 110.462 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.72 -30.8 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.69 -33.42 73.93 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.288 0.235 . . . . 0.0 110.97 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -84.61 -17.98 36.95 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.365 0.266 . . . . 0.0 111.696 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -80.88 -29.41 35.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.887 0.475 . . . . 0.0 111.5 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -127.21 8.57 6.63 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 57.63 16.29 3.33 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.972 0.909 . . . . 0.0 112.546 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 23.7 p -90.45 -176.71 4.86 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.062 0.945 . . . . 0.0 110.093 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.6 t -133.67 145.32 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -132.6 143.41 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.17 106.2 5.97 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.31 147.1 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -126.54 66.26 1.24 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 122.949 0.5 . . . . 0.0 110.898 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.57 -13.83 35.56 Favored 'General case' 0 CA--C 1.527 0.069 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -76.14 0.17 19.89 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.587 0.355 . . . . 0.0 110.543 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 9.8 t -119.24 146.14 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.367 1.067 . . . . 0.0 111.175 176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -156.17 119.07 4.18 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 t -76.81 174.06 10.95 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.842 0.457 . . . . 0.0 110.293 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.5 m -63.38 -14.94 55.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -74.27 -10.61 59.77 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.38 0.672 . . . . 0.0 112.181 174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.95 -3.26 61.71 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 123.555 0.598 . . . . 0.0 112.037 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.31 163.58 21.69 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.659 0.73 . . . . 0.0 112.154 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.0 m -111.97 132.05 22.18 Favored Pre-proline 0 N--CA 1.454 -0.255 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -81.48 161.12 19.64 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.771 2.981 . . . . 0.0 111.605 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.51 152.25 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.23 158.32 35.96 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.865 0.866 . . . . 0.0 110.788 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -136.07 148.74 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -140.6 141.88 31.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.654 0.782 . . . . 0.0 109.093 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 172.12 17.99 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 121.134 0.493 . . . . 0.0 111.015 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 64' ' ' GLN . 17.9 mp0 -70.87 -29.89 66.12 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.236 0.614 . . . . 0.0 111.069 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -154.02 159.97 41.82 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.021 0.928 . . . . 0.0 109.9 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -66.66 -22.14 66.1 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 122.408 -0.182 . . . . 0.0 110.561 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -68.18 -14.49 63.02 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.381 0.272 . . . . 0.0 111.008 177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -114.54 -23.16 9.44 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.967 0.507 . . . . 0.0 111.137 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.2 t -82.86 -37.26 24.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 117.958 0.345 . . . . 0.0 110.36 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -72.78 -29.42 63.27 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 122.156 0.182 . . . . 0.0 111.292 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -70.51 -32.22 69.63 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.585 0.231 . . . . 0.0 110.826 176.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -72.84 -41.91 64.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.217 0.607 . . . . 0.0 110.898 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.54 -12.11 59.87 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.28 -33.85 32.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 118.011 0.369 . . . . 0.0 111.197 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -81.07 -10.8 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.062 0 O-C-N 122.07 -0.394 . . . . 0.0 110.889 -174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.76 -5.6 59.33 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.5 t -159.7 -36.87 0.06 Allowed 'General case' 0 N--CA 1.457 -0.095 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.07 -45.68 9.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.909 0.322 . . . . 0.0 110.887 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 49.4 mtp 52.47 9.9 0.12 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.162 1.385 . . . . 0.0 112.643 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 50.96 19.13 0.61 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.458 1.103 . . . . 0.0 113.201 -175.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 25.9 t -156.85 5.03 0.15 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -80.35 21.84 0.59 Allowed 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.629 -0.67 . . . . 0.0 111.718 -178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -66.65 -13.15 60.83 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.35 0.66 . . . . 0.0 111.889 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.4 p30 -72.0 5.32 2.75 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm . . . . . 0 C--O 1.253 1.276 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.552 178.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.2 0.048 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.36 -179.7 46.43 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -66.36 150.38 48.96 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.715 0.258 . . . . 0.0 111.176 178.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -65.23 -5.63 7.49 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.112 0.565 . . . . 0.0 111.79 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.5 ttm -76.9 -16.67 59.32 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.068 0.547 . . . . 0.0 111.095 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -135.1 11.57 3.58 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 p -139.64 158.5 44.0 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.8 m -78.61 1.23 23.4 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -69.28 147.79 11.85 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 122.894 0.478 . . . . 0.0 111.154 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.0 m -139.05 159.0 29.6 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.052 0 C-N-CA 123.062 0.545 . . . . 0.0 111.27 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -80.32 156.15 26.91 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.011 0.524 . . . . 0.0 110.414 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -145.7 148.62 33.22 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.87 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 79.9 mt -143.18 152.13 16.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 124.563 1.145 . . . . 0.0 107.939 176.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -139.98 138.39 35.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.76 0.424 . . . . 0.0 110.15 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.7 tp60 -155.45 151.11 27.38 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.483 0.313 . . . . 0.0 110.918 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.43 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 67.4 m95 -95.52 148.75 22.16 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.008 0.923 . . . . 0.0 111.222 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.5 pt -138.59 140.3 27.3 Favored Pre-proline 0 C--O 1.233 0.223 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 172.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.23 148.88 91.11 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.954 2.436 . . . . 0.0 110.248 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -12.33 13.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -74.45 -8.9 57.82 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 115.449 1.648 . . . . 0.0 115.449 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -135.4 10.79 3.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.6 t -64.48 -24.43 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.8 -12.98 65.54 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -84.14 5.9 24.49 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 117.742 0.771 . . . . 0.0 110.483 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 48.9 mt -132.62 -36.3 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 123.063 0.545 . . . . 0.0 110.642 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 mt -116.61 10.9 14.55 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.607 0.763 . . . . 0.0 112.514 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.66 -14.47 65.04 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.379 -0.678 . . . . 0.0 114.123 -172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -157.16 94.61 1.42 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 118.48 1.14 . . . . 0.0 110.274 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 51.4 24.1 2.03 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.815 0.846 . . . . 0.0 112.721 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.37 23.61 4.54 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 112.581 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.24 -25.51 68.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.216 -0.302 . . . . 0.0 111.557 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.6 t -74.34 -31.43 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.78 -38.49 80.06 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.55 -23.48 64.51 Favored 'General case' 0 C--N 1.338 0.07 0 C-N-CA 123.105 0.562 . . . . 0.0 111.477 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -68.71 -36.02 77.9 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 122.227 -0.295 . . . . 0.0 110.326 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.2 mt -79.0 -29.73 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.74 -35.4 74.96 Favored 'General case' 0 N--CA 1.457 -0.122 0 O-C-N 122.103 -0.373 . . . . 0.0 111.601 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -84.4 -14.67 48.77 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.112 0.415 . . . . 0.0 111.006 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -78.44 -29.73 47.18 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.574 0.35 . . . . 0.0 111.177 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -129.09 7.32 5.48 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.6 t30 56.7 20.79 5.33 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.325 1.05 . . . . 0.0 111.389 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 27.7 p -90.86 -177.9 5.09 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.497 0.719 . . . . 0.0 110.103 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.0 t -131.89 146.1 33.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.2 mt -133.6 144.56 35.59 Favored 'Isoleucine or valine' 0 C--N 1.337 0.065 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.43 113.75 8.98 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 54.4 t -83.92 140.77 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -114.93 70.24 0.73 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.777 0.431 . . . . 0.0 110.852 -177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.5 p -62.74 -9.99 11.22 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -72.79 1.34 8.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.192 0.997 . . . . 0.0 110.187 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -131.94 142.97 41.58 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.117 0 C-N-CA 124.427 1.091 . . . . 0.0 111.759 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -145.8 122.22 10.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.482 0.713 . . . . 0.0 109.347 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 43.9 t -77.09 165.28 24.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.398 177.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.5 m -65.26 -17.33 64.41 Favored 'General case' 0 C--O 1.231 0.086 0 C-N-CA 122.946 0.498 . . . . 0.0 111.056 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.37 3.1 p90 -88.57 8.4 28.46 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.28 41.69 45.23 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 119.865 -0.408 . . . . 0.0 112.416 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 150.75 51.5 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.473 0.636 . . . . 0.0 112.455 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -102.16 130.11 24.92 Favored Pre-proline 0 N--CA 1.452 -0.331 0 C-N-CA 124.831 1.252 . . . . 0.0 113.483 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -80.17 153.19 21.55 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.944 2.43 . . . . 0.0 110.545 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -138.14 155.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 124.064 0.945 . . . . 0.0 112.497 177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -122.47 155.37 36.3 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.738 0.815 . . . . 0.0 111.046 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.5 mt -134.25 145.29 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.71 138.12 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 C-N-CA 123.23 0.612 . . . . 0.0 110.928 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.8 163.97 34.11 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 122.774 0.43 . . . . 0.0 110.247 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -76.67 -15.56 59.77 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -147.69 154.33 40.45 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.812 0.445 . . . . 0.0 110.685 -177.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -66.54 -27.55 67.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.9 mp0 -69.32 -2.62 11.25 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.438 0.695 . . . . 0.0 111.817 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -124.38 -23.8 4.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.63 0.372 . . . . 0.0 110.84 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -80.72 -39.58 26.77 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -72.76 -28.46 62.63 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.95 -32.01 66.88 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 122.127 -0.358 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.48 -28.32 41.51 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.262 0.225 . . . . 0.0 110.589 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -70.7 -40.56 72.81 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.556 0.342 . . . . 0.0 111.145 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -80.16 -11.55 59.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.0 -31.46 25.46 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.088 0.404 . . . . 0.0 111.251 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.59 -11.56 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 CA-C-N 118.207 0.458 . . . . 0.0 110.59 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.15 -6.2 59.36 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.6 t -158.91 -38.28 0.06 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.755 0.707 . . . . 0.0 112.773 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' C ' ' H ' ' A' ' 81' ' ' GLN . 67.5 mt -84.66 -49.7 8.3 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 117.805 0.275 . . . . 0.0 110.916 -177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.0 mtp 54.68 0.57 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.831 1.652 . . . . 0.0 113.333 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 79' ' ' LEU . 72.7 mm-40 52.26 18.38 0.88 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.031 1.332 . . . . 0.0 112.957 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.8 t -84.71 7.65 19.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.815 0.846 . . . . 0.0 112.149 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -62.0 147.86 45.75 Favored 'General case' 0 N--CA 1.456 -0.149 0 O-C-N 121.914 -0.491 . . . . 0.0 111.613 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -82.62 15.72 2.47 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.423 0.689 . . . . 0.0 112.516 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.256 53.1 m-20 61.19 28.22 17.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.093 178.13 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.4 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.533 0.206 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.89 -179.51 48.81 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.4 m -66.97 154.58 40.79 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.976 0.417 . . . . 0.0 111.049 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 m170 -73.98 165.56 24.93 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.831 0.453 . . . . 0.0 110.9 178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 73.6 mtm -80.49 3.91 20.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.289 0.636 . . . . 0.0 112.485 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -146.4 23.61 1.29 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.92 150.98 19.15 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 178.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 46.0 t -71.24 -15.52 62.45 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.698 0.399 . . . . 0.0 110.814 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.67 138.16 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.5 m -147.01 156.71 10.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -82.86 160.41 22.18 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.718 0.807 . . . . 0.0 110.578 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -144.51 149.4 35.86 Favored 'General case' 0 CA--C 1.521 -0.158 0 C-N-CA 123.218 0.607 . . . . 0.0 112.341 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -144.02 151.59 16.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 125.159 1.384 . . . . 0.0 107.858 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -142.27 137.65 30.82 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.002 0.521 . . . . 0.0 109.637 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -158.27 149.63 21.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.733 0.301 . . . . 0.0 111.509 -179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.1 m95 -92.54 148.13 22.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.094 0.957 . . . . 0.0 111.425 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.4 pt -138.95 147.56 54.4 Favored Pre-proline 0 C--O 1.232 0.175 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -62.96 142.41 88.01 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.812 2.341 . . . . 0.0 109.733 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -15.85 29.86 Favored 'General case' 0 N--CA 1.458 -0.033 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.91 -12.0 59.94 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -112.91 -3.38 14.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.56 0.344 . . . . 0.0 111.548 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.4 t -63.73 -26.49 40.77 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.27 -14.68 74.33 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-O 119.632 -0.538 . . . . 0.0 111.93 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -78.68 -32.49 47.09 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.081 0.941 . . . . 0.0 110.166 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.4 mt -85.4 -43.56 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 122.585 0.354 . . . . 0.0 110.892 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 71.4 mt -93.05 0.65 57.39 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.91 157.53 52.23 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 53.4 t30 50.29 54.86 10.38 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.532 0.733 . . . . 0.0 110.959 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 55.77 37.94 29.47 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.427 0.691 . . . . 0.0 111.813 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.0 23.62 8.55 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.338 1.055 . . . . 0.0 112.846 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.94 -23.24 66.23 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 121.695 -0.628 . . . . 0.0 111.027 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.4 t -73.48 -37.65 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.97 -40.65 83.12 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -69.75 -16.23 63.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.477 0.711 . . . . 0.0 111.514 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -81.18 -33.15 33.22 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.076 0.398 . . . . 0.0 110.801 176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.76 -30.77 18.86 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.18 -31.15 69.57 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -91.47 -13.2 32.63 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.171 0.441 . . . . 0.0 110.923 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.9 tp60 -78.04 -28.17 48.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 122.841 0.457 . . . . 0.0 110.929 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -130.53 6.19 4.78 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 58.52 17.18 4.72 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.228 1.011 . . . . 0.0 112.486 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 80.7 m -87.91 -179.84 6.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.741 0.817 . . . . 0.0 110.33 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.6 t -131.4 145.41 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.5 144.02 38.08 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.067 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.91 112.45 9.34 Favored 'General case' 0 CA--C 1.522 -0.111 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.51 147.38 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -128.06 65.11 1.38 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.197 0.599 . . . . 0.0 110.735 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.4 -10.35 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -72.34 0.95 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.355 1.062 . . . . 0.0 110.245 172.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.83 143.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 124.747 1.219 . . . . 0.0 112.005 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.87 120.54 3.84 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.5 t -81.6 170.45 15.83 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.895 0.478 . . . . 0.0 110.277 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -62.56 -13.41 30.76 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.597 0.359 . . . . 0.0 110.957 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -68.01 -12.24 60.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.57 34.38 49.78 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.22 154.9 50.99 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.189 0.596 . . . . 0.0 111.828 -175.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -108.41 134.18 20.32 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.26 155.42 25.37 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.33 2.687 . . . . 0.0 111.729 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 t -138.76 152.18 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.516 1.127 . . . . 0.0 110.444 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.51 155.75 44.36 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.514 0.726 . . . . 0.0 110.906 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.3 mt -136.99 148.34 26.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 C-N-CA 123.384 0.674 . . . . 0.0 109.319 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.7 t -139.16 142.67 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.667 0.787 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.59 166.23 29.34 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.984 0.513 . . . . 0.0 110.166 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -75.4 -16.58 60.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -156.28 164.13 38.7 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.913 -0.492 . . . . 0.0 111.824 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -73.22 -18.01 61.29 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 122.659 0.383 . . . . 0.0 110.86 178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -71.27 -4.92 28.47 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.971 0.509 . . . . 0.0 111.721 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -132.33 -27.81 1.74 Allowed 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.606 0.363 . . . . 0.0 111.319 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 t -68.35 -33.24 73.92 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -73.9 -28.8 61.73 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 122.135 0.174 . . . . 0.0 111.159 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -71.78 -34.9 69.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.09 -19.92 50.02 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.377 0.271 . . . . 0.0 110.794 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.0 tpt85 -79.56 -45.1 19.86 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.257 0.623 . . . . 0.0 110.881 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -77.39 -11.85 59.89 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 112.408 0.522 . . . . 0.0 112.408 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.23 -17.16 47.04 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.46 -5.68 9.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.083 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.7 mmt -83.96 -6.99 59.52 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 t -158.94 -36.38 0.06 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.87 0.759 . . . . 0.0 112.894 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.4 mt -88.89 -46.68 8.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 118.104 0.411 . . . . 0.0 111.033 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 46.2 mtp 53.68 10.83 0.26 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.966 1.306 . . . . 0.0 112.441 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 52.07 18.79 0.89 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.549 1.14 . . . . 0.0 113.048 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.1 t -162.25 -15.57 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -68.4 146.96 52.74 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 121.779 -0.576 . . . . 0.0 109.694 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -149.69 0.32 0.48 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -81.32 3.76 23.01 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.178 -1.391 . . . . 0.0 110.718 -179.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.6 m . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.507 0.194 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.56 -177.89 44.98 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.8 t -67.12 147.88 52.55 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.966 0.412 . . . . 0.0 111.191 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -84.81 0.52 50.49 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.944 0.498 . . . . 0.0 111.582 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 46.8 ttp 57.46 18.36 4.44 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.451 1.101 . . . . 0.0 111.956 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -80.63 4.09 19.78 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.132 0.573 . . . . 0.0 111.659 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.11 153.1 31.01 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.8 p -73.78 -10.6 59.84 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.54 147.18 11.6 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 33.1 m -144.8 156.23 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-O 121.391 0.615 . . . . 0.0 110.457 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -81.41 157.91 24.81 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 110.656 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -141.0 144.89 35.29 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.4 mt -144.95 150.99 15.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 125.071 1.348 . . . . 0.0 108.652 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -141.8 137.89 31.85 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -155.46 148.16 24.19 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 110.708 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -93.09 148.24 22.18 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.547 0.739 . . . . 0.0 111.373 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.88 143.71 41.08 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 173.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.79 155.13 70.84 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.992 2.461 . . . . 0.0 110.24 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.94 -19.93 47.35 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -79.05 -10.86 59.95 Favored 'General case' 0 C--N 1.338 0.093 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 175.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -105.86 -9.1 17.35 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 123.38 0.672 . . . . 0.0 111.729 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 96.8 t -67.2 -30.61 49.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.72 -17.05 79.08 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -82.34 2.07 34.03 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 117.584 0.692 . . . . 0.0 111.573 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.9 mt -127.03 -31.55 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 C-N-CA 122.707 0.403 . . . . 0.0 110.826 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -118.59 5.6 11.65 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.386 0.674 . . . . 0.0 112.672 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.79 -1.8 55.38 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.883 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -148.65 60.78 1.08 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 118.184 0.992 . . . . 0.0 111.274 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 56.02 31.64 18.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.431 0.693 . . . . 0.0 111.073 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.02 24.41 9.5 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.589 1.155 . . . . 0.0 113.361 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.94 -22.83 67.05 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.048 0.386 . . . . 0.0 111.294 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 50.5 t -73.46 -38.72 53.53 Favored 'Isoleucine or valine' 0 C--N 1.339 0.132 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -67.82 -35.33 78.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -69.83 -18.41 63.44 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.324 0.65 . . . . 0.0 112.015 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 63.0 t60 -77.18 -37.93 52.64 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.313 0.506 . . . . 0.0 110.419 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mt -70.9 -31.46 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.22 -26.62 65.8 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.514 0.325 . . . . 0.0 111.19 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -90.67 -21.45 21.64 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.973 0.509 . . . . 0.0 111.216 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -78.78 -28.48 44.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.559 0.744 . . . . 0.0 111.534 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -127.64 6.41 6.2 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 58.7 t30 56.08 19.83 3.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.798 0.839 . . . . 0.0 111.234 -175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.7 p -92.61 -177.22 4.51 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.94 0.896 . . . . 0.0 110.468 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.5 t -133.53 142.63 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.08 145.44 34.78 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.098 0 CA-C-O 120.87 0.367 . . . . 0.0 110.336 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -134.85 142.82 46.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.1 t -115.47 149.08 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 122.59 0.356 . . . . 0.0 110.862 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -126.3 52.72 1.69 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.65 0.78 . . . . 0.0 112.149 -173.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.42 -12.42 14.42 Favored 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.9 pm0 -72.2 -12.78 61.32 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.395 0.278 . . . . 0.0 111.723 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -85.11 165.02 2.37 Favored 'Isoleucine or valine' 0 C--N 1.339 0.126 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -146.99 76.16 1.41 Allowed 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.9 p -72.65 163.38 28.16 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.005 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.97 -9.07 57.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -80.13 -9.95 59.74 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.867 0.467 . . . . 0.0 110.057 178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.3 31.53 74.54 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.05 165.06 28.41 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.217 0.509 . . . . 0.0 111.378 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.6 m -110.91 131.43 22.14 Favored Pre-proline 0 N--CA 1.456 -0.151 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -82.32 155.39 16.66 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.53 2.82 . . . . 0.0 110.69 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.07 157.15 41.69 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 124.082 0.953 . . . . 0.0 111.685 175.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -128.46 151.72 49.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.273 0.629 . . . . 0.0 110.751 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -139.22 147.15 24.79 Favored 'Isoleucine or valine' 0 C--O 1.23 0.073 0 C-N-CA 123.157 0.583 . . . . 0.0 109.539 -177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.8 142.42 32.41 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 123.521 0.728 . . . . 0.0 109.227 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.35 173.71 16.52 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -72.8 -20.3 61.18 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 122.416 0.286 . . . . 0.0 111.531 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 p30 -162.79 168.58 21.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.63 0.372 . . . . 0.0 111.387 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -70.06 -22.83 63.03 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 122.163 -0.335 . . . . 0.0 111.752 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.0 -5.31 25.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.865 0.466 . . . . 0.0 111.784 -177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -132.13 -22.53 2.27 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.169 0.587 . . . . 0.0 111.196 178.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -76.22 -39.62 54.15 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -69.99 -35.36 74.34 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -71.09 -31.03 67.29 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.33 -23.15 50.97 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.473 0.309 . . . . 0.0 110.893 177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.0 ttt-85 -78.63 -49.2 13.63 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -71.92 -15.68 62.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.603 -176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.14 -2.59 35.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 122.68 0.392 . . . . 0.0 111.171 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.04 -5.28 11.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 123.553 0.741 . . . . 0.0 111.704 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.7 mmt -83.52 -12.8 55.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.641 -0.662 . . . . 0.0 112.686 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 46.0 t -159.89 -36.7 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.497 0.59 . . . . 0.0 112.463 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.0 mt -81.09 -43.52 19.35 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 117.868 0.303 . . . . 0.0 110.739 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.3 mtp 56.97 -1.94 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.279 1.832 . . . . 0.0 114.3 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.5 mm-40 50.72 24.73 1.81 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.613 1.165 . . . . 0.0 112.458 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.4 p -73.97 6.83 3.03 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.322 1.049 . . . . 0.0 113.59 -174.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -64.43 160.8 18.35 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.421 0.688 . . . . 0.0 111.529 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -72.42 -8.73 56.54 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.654 0.382 . . . . 0.0 111.838 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -74.66 70.25 1.82 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.588 0.755 . . . . 0.0 111.781 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.043 -1.456 . . . . 0.0 110.884 179.286 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.18 179.84 48.78 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.6 t -157.35 157.23 33.72 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 122.885 0.474 . . . . 0.0 110.76 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -72.22 -4.85 31.85 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.993 0.517 . . . . 0.0 111.768 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.5 mtm -74.26 -1.99 23.01 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.108 0.563 . . . . 0.0 112.144 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -151.09 149.63 29.74 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.002 0.521 . . . . 0.0 110.269 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -70.38 162.26 28.94 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 98.5 m -129.56 6.37 5.2 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.592 0.757 . . . . 0.0 111.338 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.75 147.81 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.125 0.57 . . . . 0.0 111.609 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.4 m -145.34 155.48 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.874 0.87 . . . . 0.0 110.704 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.88 153.26 22.35 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.114 175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -142.65 155.52 44.94 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.24 0.543 . . . . 0.0 112.294 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.0 mt -142.76 152.35 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 125.252 1.421 . . . . 0.0 107.85 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -141.49 142.54 33.61 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -159.98 156.19 26.68 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.534 0.334 . . . . 0.0 110.41 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.413 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 57.4 m95 -100.37 147.12 26.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.723 0.809 . . . . 0.0 109.996 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.91 143.9 50.91 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 174.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -66.88 152.18 80.91 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.884 2.389 . . . . 0.0 110.264 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.74 -14.21 30.13 Favored 'General case' 0 C--N 1.334 -0.104 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -85.59 -11.06 54.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -115.22 -20.01 10.56 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -66.67 -25.07 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 O-C-N 121.824 -0.547 . . . . 0.0 111.271 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.5 -14.84 74.97 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.36 -15.64 32.85 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.132 0.966 . . . . 0.0 111.267 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.2 mt -98.44 -30.65 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.587 0.355 . . . . 0.0 110.78 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.3 mt -118.3 -9.15 10.47 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -173.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 -7.28 83.35 Favored Glycine 0 CA--C 1.525 0.717 0 O-C-N 122.076 -0.39 . . . . 0.0 113.253 -176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -117.71 50.37 1.14 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.561 0.745 . . . . 0.0 109.334 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 54.66 28.41 9.97 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.609 0.764 . . . . 0.0 111.36 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.68 19.3 3.28 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.851 1.26 . . . . 0.0 113.1 -175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.62 -23.56 67.13 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.92 -0.488 . . . . 0.0 110.606 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.99 -40.01 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 176.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -68.99 -42.34 76.64 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -67.15 -22.72 65.76 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 123.659 0.784 . . . . 0.0 112.151 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -81.89 -29.29 32.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.282 0.492 . . . . 0.0 110.802 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -73.35 -29.61 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.031 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -67.51 -28.24 67.66 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.5 ttt85 -85.59 -19.58 30.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.968 0.907 . . . . 0.0 111.178 177.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -82.55 -28.29 31.08 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.56 0.744 . . . . 0.0 111.577 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -127.51 6.41 6.28 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 115.882 1.808 . . . . 0.0 115.882 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 57.03 15.41 2.36 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.968 0.907 . . . . 0.0 112.263 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.0 p -89.82 -177.62 5.29 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.238 1.015 . . . . 0.0 110.431 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.6 t -131.49 146.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.2 140.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -138.78 107.09 5.79 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -79.33 124.96 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.795 0.331 . . . . 0.0 110.34 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -94.45 69.11 3.57 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.496 0.718 . . . . 0.0 110.929 -175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -65.58 -11.0 40.25 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -76.04 -10.3 59.31 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.161 -0.337 . . . . 0.0 110.602 175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 t -98.71 155.33 3.87 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.65 0.78 . . . . 0.0 110.817 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -147.27 122.11 9.96 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.879 0.472 . . . . 0.0 109.77 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.413 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 45.9 t -75.13 168.46 19.94 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.344 0.658 . . . . 0.0 111.034 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 67.3 m -64.68 -8.6 15.16 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.201 0.6 . . . . 0.0 111.248 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.355 4.5 p90 -117.93 12.39 13.73 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.31 -1.59 84.79 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.298 -0.723 . . . . 0.0 113.884 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.57 153.55 43.31 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.367 1.084 . . . . 0.0 111.655 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.1 m -103.93 126.4 31.91 Favored Pre-proline 0 C--N 1.333 -0.124 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.18 156.94 26.27 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 123.079 2.519 . . . . 0.0 110.689 176.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.17 147.61 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -117.38 158.92 23.61 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.68 0.792 . . . . 0.0 111.0 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -133.85 148.32 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.1 t -138.11 137.91 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.226 0.611 . . . . 0.0 111.791 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.62 168.67 25.49 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.854 0.461 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -72.4 -18.46 61.72 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.381 0.272 . . . . 0.0 111.483 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -156.26 163.61 39.34 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.698 0.399 . . . . 0.0 111.608 -178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -72.21 -17.1 61.95 Favored 'General case' 0 C--N 1.337 0.064 0 C-N-CA 122.334 0.253 . . . . 0.0 111.14 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -70.02 -7.45 41.1 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.062 0.545 . . . . 0.0 111.435 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -130.77 -21.66 2.73 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.239 0.616 . . . . 0.0 111.187 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.2 t -73.98 -38.75 64.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -71.04 -30.6 66.83 Favored 'General case' 0 C--N 1.337 0.058 0 C-N-CA 122.165 0.186 . . . . 0.0 111.004 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -72.98 -31.33 64.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.02 -22.62 48.96 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.412 0.285 . . . . 0.0 110.998 177.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 38.7 ttt85 -72.7 -55.49 6.71 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -65.48 -16.71 63.93 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.402 -178.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.84 -2.47 39.86 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.916 0.487 . . . . 0.0 111.759 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.19 -19.51 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.191 0 C-N-CA 123.05 0.54 . . . . 0.0 111.518 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 mmt -85.39 -5.62 59.29 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.1 t -158.31 -39.49 0.06 Allowed 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.334 0.516 . . . . 0.0 112.254 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -81.69 -39.45 24.27 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.973 0.351 . . . . 0.0 111.333 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.9 mtp 50.52 21.67 0.91 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.649 1.18 . . . . 0.0 112.298 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.4 tm0? 50.47 29.53 4.03 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.992 1.317 . . . . 0.0 111.507 -174.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 46.9 t -65.77 -19.52 65.92 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.748 0.419 . . . . 0.0 111.778 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -69.84 132.03 45.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 122.079 -0.388 . . . . 0.0 110.547 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -87.09 -12.61 46.67 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -90.68 4.5 51.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.734 -1.127 . . . . 0.0 110.38 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 N--CA 1.475 0.786 0 CA-C-O 120.57 0.224 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.96 -179.88 46.79 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -157.08 169.96 23.6 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -68.05 -8.63 39.39 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 122.581 0.352 . . . . 0.0 111.669 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.3 mtp -80.92 -5.92 58.03 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.083 0.553 . . . . 0.0 111.311 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -66.59 145.83 55.17 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 123.025 0.53 . . . . 0.0 111.071 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.7 167.67 19.37 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.0 t -131.66 23.59 4.69 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.35 0.66 . . . . 0.0 109.48 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.24 144.95 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 122.923 0.489 . . . . 0.0 111.196 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.5 m -143.57 155.48 16.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 123.597 0.759 . . . . 0.0 109.556 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -81.51 161.96 23.41 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 123.199 0.599 . . . . 0.0 111.05 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -144.7 148.89 34.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.233 0.613 . . . . 0.0 112.214 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mt -145.02 150.78 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.83 1.252 . . . . 0.0 108.171 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.35 135.99 24.36 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.104 0.561 . . . . 0.0 110.042 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -158.35 149.7 21.01 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.533 0.333 . . . . 0.0 110.774 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.0 m95 -89.81 148.74 23.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.108 0.963 . . . . 0.0 111.276 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.66 143.79 46.3 Favored Pre-proline 0 CA--C 1.53 0.196 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 171.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.06 145.75 94.17 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.184 2.589 . . . . 0.0 109.999 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.3 -11.69 7.16 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 115.562 1.689 . . . . 0.0 115.562 -178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.46 -8.24 56.19 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 pt-20 -133.57 4.06 3.61 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 55.8 t -63.22 -27.07 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.7 -13.95 72.17 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.236 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -81.01 -26.01 36.78 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.078 0.939 . . . . 0.0 111.113 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.2 mt -86.37 -42.1 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.098 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.74 0.71 55.2 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.59 152.22 51.6 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 47.94 63.98 1.82 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.072 0.949 . . . . 0.0 111.118 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 47.9 mtm180 56.71 33.7 23.34 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 122.795 0.438 . . . . 0.0 111.885 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.05 25.38 8.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.206 1.002 . . . . 0.0 112.724 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.24 -23.23 65.49 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.896 -0.502 . . . . 0.0 111.39 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.9 t -73.3 -37.53 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -70.02 -39.84 75.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.38 -23.79 64.71 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.414 0.685 . . . . 0.0 111.775 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -71.93 -34.1 68.77 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 117.566 0.166 . . . . 0.0 110.78 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.9 mt -74.93 -30.63 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -68.34 -32.01 71.81 Favored 'General case' 0 C--N 1.334 -0.082 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 13.0 ptm85 -89.47 -13.88 36.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.067 0.394 . . . . 0.0 110.935 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -81.26 -29.14 34.46 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.996 0.519 . . . . 0.0 111.125 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -127.63 8.75 6.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 56.59 15.58 2.17 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.26 1.024 . . . . 0.0 112.414 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.4 p -90.15 -178.5 5.43 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.264 1.026 . . . . 0.0 110.587 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.3 t -132.63 144.98 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.2 mt -132.56 142.17 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.45 111.46 8.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -81.11 146.7 7.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.55 65.91 1.33 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.079 0.552 . . . . 0.0 110.69 -177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -61.68 -10.5 8.7 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -71.27 0.34 8.2 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.992 0.917 . . . . 0.0 110.42 172.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.58 143.73 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 124.688 1.195 . . . . 0.0 111.55 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -157.54 118.27 3.52 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 25.8 t -85.94 169.8 12.91 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.593 0.357 . . . . 0.0 110.184 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 t -63.48 -10.89 19.69 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 122.73 0.412 . . . . 0.0 110.913 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.26 -13.59 62.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 176.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.75 34.24 44.14 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.97 161.29 36.06 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.4 m -117.68 134.84 23.17 Favored Pre-proline 0 C--O 1.233 0.222 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.83 155.59 26.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.293 2.662 . . . . 0.0 111.424 178.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.1 t -138.91 146.19 26.53 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.097 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -119.39 154.71 33.23 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.362 0.665 . . . . 0.0 110.934 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.6 mt -136.89 146.6 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.644 0.778 . . . . 0.0 109.1 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.14 138.69 40.92 Favored 'Isoleucine or valine' 0 C--N 1.338 0.071 0 C-N-CA 123.661 0.784 . . . . 0.0 109.632 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.57 168.2 27.96 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.999 0.428 . . . . 0.0 110.707 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -71.81 -21.96 61.63 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.496 -177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -160.44 167.34 27.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.836 0.289 . . . . 0.0 111.2 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -71.44 -25.31 62.25 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.363 0.265 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 61.7 mp0 -69.55 -2.25 10.93 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.354 0.662 . . . . 0.0 112.004 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -131.98 -25.12 2.07 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.941 0.496 . . . . 0.0 111.265 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.5 t -73.51 -37.1 65.79 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -74.11 -29.09 61.67 Favored 'General case' 0 C--N 1.338 0.088 0 O-C-N 122.364 -0.21 . . . . 0.0 111.255 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -73.8 -32.0 63.54 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.08 -22.71 52.39 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.133 0.173 . . . . 0.0 110.75 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.45 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 12.9 tpt180 -75.12 -51.49 13.33 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.693 0.797 . . . . 0.0 110.425 176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -70.49 -14.15 62.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.16 -1.67 55.45 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.898 0.479 . . . . 0.0 111.918 177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 99.1 t -122.69 -12.93 7.16 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 CA-C-N 118.192 0.451 . . . . 0.0 111.577 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.45 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 17.4 mmt -90.97 -0.53 57.76 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 37.1 t -158.48 -40.04 0.06 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 81' ' ' GLN . 59.9 mt -87.55 -42.04 13.03 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-N 117.838 0.29 . . . . 0.0 111.498 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.6 mtp 57.08 -3.57 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 126.083 1.753 . . . . 0.0 114.114 -178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' LEU . 69.3 mm-40 49.79 21.64 0.7 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.722 1.209 . . . . 0.0 113.42 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 87.9 p -76.97 7.48 4.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.41 0.684 . . . . 0.0 111.869 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -72.56 16.02 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.965 0.906 . . . . 0.0 112.59 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -70.22 -13.63 62.26 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.087 0.555 . . . . 0.0 111.04 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.261 69.6 m-20 58.09 12.57 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 67.9 mttm . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.222 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 90.1 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.562 0.22 . . . . 0.0 110.546 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.93 6.66 87.39 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -65.86 147.62 53.08 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.782 0.791 . . . . 0.0 110.829 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -158.67 153.12 24.26 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.153 0.581 . . . . 0.0 110.222 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.16 -9.34 48.56 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.619 0.368 . . . . 0.0 111.816 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -74.21 166.61 23.15 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.887 0.475 . . . . 0.0 110.943 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -64.03 160.46 17.95 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.9 m -119.0 -1.68 10.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.152 0.581 . . . . 0.0 111.545 177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.79 147.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 122.772 0.429 . . . . 0.0 111.377 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m -142.21 153.27 18.34 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -88.12 162.03 16.97 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.941 0.897 . . . . 0.0 111.0 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -144.08 150.08 37.6 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.135 0.574 . . . . 0.0 112.133 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -144.51 150.44 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.13 176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.87 138.81 34.2 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -160.2 149.38 17.46 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.691 0.281 . . . . 0.0 110.988 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -92.29 146.31 23.8 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 124.066 0.946 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.64 146.82 63.06 Favored Pre-proline 0 C--O 1.232 0.143 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -62.6 139.48 75.95 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.917 2.411 . . . . 0.0 109.903 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.37 -14.85 20.96 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.4 p -78.06 -13.06 60.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -106.89 -10.74 15.91 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 111.034 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.15 -24.04 34.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 O-C-N 121.923 -0.486 . . . . 0.0 109.74 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.87 -15.06 66.45 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.03 -23.09 22.67 Favored 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.119 0.959 . . . . 0.0 111.076 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.2 mt -87.2 -32.55 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 119.525 -0.274 . . . . 0.0 110.853 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.05 -14.03 7.66 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -79.28 12.06 27.6 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.081 0.372 . . . . 0.0 113.194 -174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -139.51 45.46 1.93 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.833 0.853 . . . . 0.0 110.659 -176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 43.8 mtp180 56.26 28.21 12.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.221 0.608 . . . . 0.0 110.58 -173.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.38 26.4 12.45 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.902 1.281 . . . . 0.0 112.957 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.56 -26.96 67.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.627 0.371 . . . . 0.0 111.745 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.46 -38.77 47.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -72.9 -40.48 65.48 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 118.327 0.512 . . . . 0.0 109.838 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -68.89 -26.97 65.37 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -73.23 -42.57 62.45 Favored 'General case' 0 N--CA 1.46 0.052 0 O-C-N 121.958 -0.464 . . . . 0.0 110.828 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.56 -28.52 38.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.512 0.196 . . . . 0.0 110.548 -176.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -68.29 -28.83 67.53 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.939 -0.476 . . . . 0.0 111.239 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.2 mtp85 -88.91 -18.03 28.37 Favored 'General case' 0 C--O 1.225 -0.208 0 C-N-CA 122.357 0.263 . . . . 0.0 111.114 177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -78.64 -27.47 45.38 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.446 0.699 . . . . 0.0 111.383 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -129.54 6.3 5.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.5 t30 56.8 17.88 3.47 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.235 1.014 . . . . 0.0 111.457 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -89.17 -177.63 5.46 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.926 0.89 . . . . 0.0 110.687 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.34 144.92 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.3 mt -133.09 142.18 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.47 115.7 12.55 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -83.51 148.7 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -131.53 61.66 1.64 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 123.037 0.535 . . . . 0.0 111.652 -176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -12.55 6.72 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -70.62 -16.08 62.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.935 0.894 . . . . 0.0 111.028 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.0 t -88.94 150.71 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 123.02 0.528 . . . . 0.0 111.003 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -142.91 129.78 20.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 33.0 t -141.93 167.13 22.87 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 122.826 0.451 . . . . 0.0 110.606 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 94.1 p -65.21 -5.64 7.45 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.068 0.547 . . . . 0.0 111.505 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -67.96 -17.93 64.59 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.91 75.34 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.58 166.27 25.11 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.244 0.618 . . . . 0.0 111.416 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -111.19 131.58 22.14 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.44 155.34 28.3 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.51 2.807 . . . . 0.0 111.315 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.11 148.09 25.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 C-N-CA 124.448 1.099 . . . . 0.0 110.791 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -121.75 154.12 37.36 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.431 0.692 . . . . 0.0 110.656 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mt -138.25 147.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.152 0.581 . . . . 0.0 109.649 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 38.8 t -138.31 140.57 39.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 123.73 0.812 . . . . 0.0 110.632 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -158.18 166.98 31.06 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 122.736 0.414 . . . . 0.0 110.226 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -70.58 -22.54 62.56 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.18 0.192 . . . . 0.0 111.382 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -155.82 166.27 34.0 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.154 0.582 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -69.32 -18.08 63.78 Favored 'General case' 0 CA--C 1.528 0.106 0 O-C-N 122.177 -0.327 . . . . 0.0 110.739 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -72.79 -4.44 31.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.254 0.622 . . . . 0.0 111.349 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -126.76 -24.24 3.57 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.124 0.569 . . . . 0.0 111.323 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.9 t -75.6 -39.48 57.9 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -74.62 -30.78 61.79 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.365 -0.209 . . . . 0.0 111.443 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -73.28 -29.95 63.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.02 45.01 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 122.427 0.291 . . . . 0.0 111.044 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 34.4 ttt85 -71.25 -54.58 10.41 Favored 'General case' 0 C--N 1.339 0.113 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -65.12 -14.25 60.08 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.885 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.96 -6.06 58.82 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.755 0.422 . . . . 0.0 111.727 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.2 t -125.83 -13.16 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.33 0.652 . . . . 0.0 111.754 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.1 mmt -90.28 -2.16 57.99 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.5 t -158.44 -39.66 0.06 Allowed 'General case' 0 C--N 1.338 0.094 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -85.86 -44.54 12.34 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.975 0.352 . . . . 0.0 111.688 -176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.8 mtp 50.64 24.48 1.68 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.355 1.062 . . . . 0.0 112.402 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 56.96 11.8 1.05 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.649 1.179 . . . . 0.0 112.417 -175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 83.4 p -78.11 -11.95 59.95 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.582 -0.699 . . . . 0.0 111.162 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.67 167.66 16.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.005 0.522 . . . . 0.0 111.58 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 56.1 21.47 5.16 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.107 0.963 . . . . 0.0 112.951 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -69.94 -11.58 60.98 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 62.4 mttp . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.451 -1.261 . . . . 0.0 110.461 -177.918 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.9 t . . . . . 0 N--CA 1.474 0.726 0 N-CA-C 110.467 -0.197 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.86 174.74 47.28 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -76.21 -9.68 58.82 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.335 0.654 . . . . 0.0 111.93 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -72.39 152.99 41.68 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 122.919 0.488 . . . . 0.0 110.851 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 95.1 mmm -79.82 -6.49 57.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.72 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -154.59 151.62 29.06 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 123.697 0.799 . . . . 0.0 109.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.61 157.66 31.89 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -82.2 1.35 36.87 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.35 0.66 . . . . 0.0 111.936 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.43 141.56 16.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 122.608 0.363 . . . . 0.0 111.779 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.3 m -144.86 153.99 14.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 C-N-CA 123.466 0.707 . . . . 0.0 111.704 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -85.41 161.32 19.49 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.393 0.677 . . . . 0.0 109.98 173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -145.77 151.25 37.66 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.17 0.509 . . . . 0.0 112.074 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 mt -144.12 148.71 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 124.853 1.261 . . . . 0.0 108.095 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -137.44 134.61 36.02 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -156.49 152.25 27.14 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.764 0.316 . . . . 0.0 110.773 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -99.19 151.33 21.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.896 0.878 . . . . 0.0 110.86 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.7 pt -137.31 144.69 46.61 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.09 138.59 62.71 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.365 2.043 . . . . 0.0 109.658 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -14.28 26.36 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -177.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -81.5 -8.24 59.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.22 -4.48 10.49 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.109 0.564 . . . . 0.0 111.749 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.18 -23.33 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.95 -15.4 69.28 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 119.691 -0.505 . . . . 0.0 112.166 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -83.78 -5.34 59.17 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 117.98 0.89 . . . . 0.0 111.464 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 52.1 mt -118.94 -33.98 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 C-N-CA 122.393 0.277 . . . . 0.0 111.001 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 mt -120.33 4.81 10.74 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -174.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.62 2.26 59.22 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.709 -0.495 . . . . 0.0 113.42 -175.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -147.36 60.21 1.16 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.175 0.987 . . . . 0.0 111.293 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 56.14 28.7 13.42 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.279 0.632 . . . . 0.0 111.497 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.04 25.79 9.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.538 1.135 . . . . 0.0 112.853 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.09 -24.91 67.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.887 -0.508 . . . . 0.0 111.275 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 98.2 t -73.29 -38.02 53.04 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -68.77 -41.0 79.41 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.72 -21.68 65.29 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.138 0.575 . . . . 0.0 111.68 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 50.8 t60 -75.78 -30.91 59.27 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 117.792 0.269 . . . . 0.0 110.816 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.7 mt -74.81 -31.06 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.93 -28.94 68.71 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.4 0.28 . . . . 0.0 111.567 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.79 -5.24 42.34 Favored 'General case' 0 C--N 1.338 0.102 0 O-C-N 122.282 -0.261 . . . . 0.0 111.531 178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -89.13 -28.23 20.19 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.975 0.51 . . . . 0.0 110.781 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -131.67 9.63 4.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 57.14 17.35 3.47 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.114 0.965 . . . . 0.0 112.43 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.9 m -87.37 179.1 6.65 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 123.851 0.861 . . . . 0.0 110.657 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.3 145.06 35.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.1 mt -135.49 141.74 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -176.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -139.56 132.71 29.7 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 p -85.93 157.07 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -135.57 59.12 1.73 Allowed 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.399 0.68 . . . . 0.0 109.894 175.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -59.87 -9.9 3.41 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -68.98 -10.1 55.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.723 0.809 . . . . 0.0 110.403 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.6 t -108.9 148.49 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 124.543 1.137 . . . . 0.0 111.458 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -142.59 124.04 14.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.4 p -76.62 172.67 12.64 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.886 0.374 . . . . 0.0 111.25 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -77.35 4.8 9.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.343 0.657 . . . . 0.0 110.377 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.324 7.7 p90 -124.64 11.55 8.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 117.124 2.268 . . . . 0.0 117.124 -177.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.16 39.43 27.14 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.089 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -131.49 164.25 26.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 117.533 0.667 . . . . 0.0 111.911 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.5 m -125.14 132.78 24.39 Favored Pre-proline 0 C--O 1.232 0.166 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -81.8 156.97 18.37 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.588 2.858 . . . . 0.0 111.179 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.44 158.3 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 124.098 0.959 . . . . 0.0 112.606 176.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -116.12 149.28 39.26 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.3 1.04 . . . . 0.0 110.12 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -136.28 144.44 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -137.28 144.18 32.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 123.293 0.637 . . . . 0.0 110.391 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.36 169.18 24.56 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.694 0.398 . . . . 0.0 110.494 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -76.74 -20.3 56.68 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.868 -0.151 . . . . 0.0 111.156 176.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -156.96 163.46 39.1 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.736 0.415 . . . . 0.0 111.233 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -73.6 -23.48 59.93 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 122.64 0.376 . . . . 0.0 111.787 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -67.44 -4.78 12.21 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.165 0.586 . . . . 0.0 111.821 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -126.88 -28.24 2.96 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 122.926 0.49 . . . . 0.0 110.808 175.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.8 t -68.74 -37.11 79.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -70.25 -31.9 69.49 Favored 'General case' 0 C--N 1.339 0.127 0 O-C-N 122.234 -0.291 . . . . 0.0 110.78 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -72.25 -32.26 66.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.28 -18.92 54.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.443 0.297 . . . . 0.0 111.091 177.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -83.11 -49.55 9.39 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.642 0.258 . . . . 0.0 110.534 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -74.39 -15.05 60.94 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -76.1 -4.08 39.55 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.221 0.209 . . . . 0.0 110.724 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.4 t -116.35 -9.06 12.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 123.576 0.75 . . . . 0.0 112.47 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 mmt -81.64 -23.15 37.14 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.7 m -150.91 -33.05 0.16 Allowed 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -79.99 -35.74 37.02 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.5 mtp 51.47 20.65 1.06 Allowed 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.473 1.109 . . . . 0.0 112.08 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 51.0 31.48 6.36 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.032 1.333 . . . . 0.0 111.407 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.3 t -64.15 -19.18 65.12 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.99 -0.444 . . . . 0.0 110.994 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -155.71 141.62 18.14 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.835 0.854 . . . . 0.0 109.791 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -89.44 7.47 35.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.232 0.613 . . . . 0.0 112.04 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.258 38.7 m-20 59.91 18.28 7.34 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.534 1.133 . . . . 0.0 110.422 -178.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-O 120.719 0.295 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.56 179.64 44.35 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.2 t -154.89 158.67 39.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.499 0.72 . . . . 0.0 109.604 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.1 p80 46.29 45.0 13.03 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.455 1.102 . . . . 0.0 112.139 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 59.52 23.02 11.64 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.238 1.015 . . . . 0.0 113.381 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp 54.9 25.42 6.74 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.176 0.99 . . . . 0.0 113.059 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.1 p -66.3 159.75 25.98 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 91.0 m -78.47 -8.39 58.48 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.09 148.94 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.6 m -146.18 159.36 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 C-N-CA 123.819 0.848 . . . . 0.0 109.316 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -79.7 158.37 26.97 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 122.517 0.327 . . . . 0.0 110.609 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -146.82 148.99 32.44 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 57.8 mt -144.85 152.34 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 125.074 1.35 . . . . 0.0 108.234 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -140.13 141.16 36.1 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.173 0.589 . . . . 0.0 109.965 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -158.74 150.32 20.85 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.582 0.229 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -96.02 152.61 18.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.993 0.917 . . . . 0.0 110.687 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.5 pt -136.12 139.15 29.27 Favored Pre-proline 0 C--O 1.232 0.176 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.04 150.53 82.58 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.741 2.294 . . . . 0.0 108.931 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.28 -20.72 19.94 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -173.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 t -74.67 -14.13 60.71 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -105.01 -21.98 13.19 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 122.679 0.392 . . . . 0.0 110.762 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.12 -31.13 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-O 120.672 0.273 . . . . 0.0 110.625 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.47 -8.82 67.5 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 119.758 -0.468 . . . . 0.0 112.174 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -97.03 -26.63 14.94 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 117.971 0.886 . . . . 0.0 110.592 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 73.7 mt -88.84 -32.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 122.587 0.355 . . . . 0.0 110.776 -178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.31 10.55 9.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.806 0.842 . . . . 0.0 112.22 -173.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.56 -12.8 82.31 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 117.922 0.328 . . . . 0.0 112.492 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 30' ' ' ALA . 67.6 m-20 -123.96 -154.25 0.6 Allowed 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -71.58 27.52 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.274 0.63 . . . . 0.0 111.228 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 56.18 29.61 15.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.864 1.266 . . . . 0.0 112.111 -175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.71 -24.12 66.57 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.285 -0.259 . . . . 0.0 111.452 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.07 -42.17 79.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -72.88 -41.79 64.31 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -69.17 -26.45 64.86 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.968 0.507 . . . . 0.0 112.205 -177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -72.88 -37.75 67.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.326 0.512 . . . . 0.0 110.458 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.2 mt -71.96 -29.08 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.84 -33.31 75.33 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.095 -0.378 . . . . 0.0 111.197 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -84.82 -17.67 37.35 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 122.524 0.33 . . . . 0.0 111.434 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -78.81 -27.26 44.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 111.541 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -130.08 8.86 5.22 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.2 t30 56.75 18.97 4.05 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.965 0.906 . . . . 0.0 111.969 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.0 p -90.65 -179.62 5.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.672 0.789 . . . . 0.0 110.37 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.4 t -132.26 146.14 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.95 142.23 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -135.54 135.32 40.27 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.3 p -91.48 155.12 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -134.4 60.63 1.7 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.924 0.89 . . . . 0.0 110.025 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.4 p -62.64 -11.03 14.47 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.5 pm0 -75.26 -8.41 56.56 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.308 0.243 . . . . 0.0 110.594 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -100.81 148.91 6.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.165 0 C-N-CA 123.809 0.843 . . . . 0.0 111.496 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -140.53 125.0 17.81 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 64.3 p -75.66 -177.73 3.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 121.069 0.461 . . . . 0.0 110.146 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.1 t -65.99 -8.37 22.51 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.908 0.483 . . . . 0.0 110.778 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.334 5.6 p90 -125.72 12.27 7.93 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.9 4.69 89.6 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 123.457 0.551 . . . . 0.0 113.682 175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.16 158.65 36.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 118.292 1.046 . . . . 0.0 110.831 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.2 m -107.77 125.9 31.1 Favored Pre-proline 0 C--O 1.232 0.132 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.78 151.16 18.93 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.104 2.536 . . . . 0.0 110.947 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.47 157.51 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.019 0.928 . . . . 0.0 111.721 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -126.29 156.95 39.56 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.333 0.653 . . . . 0.0 110.845 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -135.19 148.48 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 123.518 0.727 . . . . 0.0 109.073 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -139.85 140.31 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 123.352 0.661 . . . . 0.0 109.753 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.12 165.39 33.91 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.039 0.447 . . . . 0.0 110.833 178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -76.3 -14.08 60.13 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.885 0.474 . . . . 0.0 111.173 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -150.52 153.3 35.56 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.527 0.731 . . . . 0.0 110.512 -174.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.74 -23.62 63.42 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -73.89 -2.64 24.69 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.373 0.669 . . . . 0.0 111.207 178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -122.89 -24.33 4.83 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.124 0.57 . . . . 0.0 111.24 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 t -79.37 -39.77 31.8 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -73.74 -25.56 60.25 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -177.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -71.01 -32.38 69.17 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 122.011 -0.431 . . . . 0.0 110.35 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.25 -32.62 49.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 175.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -65.15 -35.16 80.24 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 122.775 0.43 . . . . 0.0 111.012 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -90.8 -15.78 29.5 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.93 -34.66 24.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.247 0.476 . . . . 0.0 111.607 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 77.1 t -78.17 -18.65 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.1 mmt -94.44 0.52 55.46 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.2 t -155.56 -35.8 0.09 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.4 mt -86.37 -43.34 12.93 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.159 0.436 . . . . 0.0 111.197 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 68.4 mtp 49.22 23.96 0.9 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.095 0.958 . . . . 0.0 112.582 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.5 tm0? 53.93 20.9 2.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.56 1.144 . . . . 0.0 112.581 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 44.2 t -142.81 -11.15 0.78 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -68.33 159.41 31.45 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.646 -0.659 . . . . 0.0 110.424 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -147.92 -22.39 0.36 Allowed 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -78.47 65.49 3.79 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.754 -0.592 . . . . 0.0 111.756 178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.845 179.531 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.7 -178.76 48.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.9 m -71.64 -8.62 55.21 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.901 0.48 . . . . 0.0 112.256 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -144.01 158.77 43.5 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.847 0.859 . . . . 0.0 109.995 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.9 ttm -71.64 -16.43 62.27 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.509 0.324 . . . . 0.0 111.037 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -151.51 138.61 19.18 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.622 0.769 . . . . 0.0 110.144 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.01 155.67 40.55 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.6 p -69.57 -9.05 52.39 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 p -71.43 146.3 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.5 m -148.05 158.12 8.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.857 0.863 . . . . 0.0 108.982 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -80.15 152.48 29.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.247 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -143.9 155.37 44.06 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.3 mt -143.98 149.92 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 125.181 1.392 . . . . 0.0 107.794 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -144.61 139.78 28.31 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 122.721 0.408 . . . . 0.0 110.007 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -156.35 153.0 28.29 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 122.844 0.458 . . . . 0.0 110.049 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.1 m95 -94.05 145.93 24.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.392 0.677 . . . . 0.0 110.704 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.05 145.26 56.23 Favored Pre-proline 0 C--N 1.332 -0.16 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 173.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.81 151.19 86.62 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.875 2.383 . . . . 0.0 109.726 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.39 -20.27 42.76 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.1 t -75.9 -13.59 60.26 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -102.76 -8.54 20.75 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.771 0.429 . . . . 0.0 111.598 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.1 t -66.75 -26.15 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.697 -0.482 . . . . 0.0 109.697 177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.35 -14.47 77.03 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -84.49 -0.39 52.8 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.744 0.772 . . . . 0.0 111.017 177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.98 -34.77 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 C-N-CA 122.934 0.494 . . . . 0.0 110.89 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.8 mt -118.01 11.23 13.31 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.207 0.603 . . . . 0.0 112.14 -175.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.73 -9.84 66.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.578 -0.568 . . . . 0.0 113.774 -173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -155.34 84.79 1.06 Allowed 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 118.404 1.102 . . . . 0.0 110.166 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 52.65 23.89 2.88 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.838 0.855 . . . . 0.0 112.499 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 54.51 22.35 3.86 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 112.762 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.05 -23.78 67.6 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.039 -0.413 . . . . 0.0 110.994 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.29 -37.98 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.077 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -69.51 -40.51 76.91 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -67.0 -20.72 65.92 Favored 'General case' 0 C--N 1.335 -0.05 0 C-N-CA 123.613 0.765 . . . . 0.0 112.241 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -77.9 -36.08 49.98 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.335 0.516 . . . . 0.0 110.599 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.07 -28.85 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.12 -28.1 66.16 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 122.271 0.229 . . . . 0.0 111.222 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -89.13 -15.01 34.88 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 122.77 0.428 . . . . 0.0 111.363 177.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -80.34 -29.43 38.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.907 0.483 . . . . 0.0 111.099 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -129.98 8.77 5.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.0 m-20 56.96 15.78 2.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.365 1.066 . . . . 0.0 112.759 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.0 p -88.98 -176.27 5.11 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.779 0.832 . . . . 0.0 110.108 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.5 t -131.94 147.28 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.18 141.32 45.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -137.86 104.04 5.16 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.9 t -75.41 146.81 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 122.133 0.173 . . . . 0.0 110.697 174.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -126.85 64.67 1.29 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.998 0.519 . . . . 0.0 111.002 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -61.44 -9.59 5.88 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 176.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -69.38 -9.27 52.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.723 0.809 . . . . 0.0 110.476 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.56 148.47 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.368 1.067 . . . . 0.0 110.899 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -143.14 122.36 12.97 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.8 p -77.0 171.32 14.99 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.254 0.55 . . . . 0.0 110.945 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.3 p -78.15 6.39 8.14 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.599 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.325 7.4 p90 -125.03 10.08 8.15 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.57 42.28 18.12 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.72 167.35 20.68 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 117.268 0.534 . . . . 0.0 111.8 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -133.82 133.86 22.72 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -80.86 161.54 21.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.761 2.974 . . . . 0.0 111.63 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -148.0 142.31 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.67 158.07 17.23 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.094 0.958 . . . . 0.0 111.448 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.4 mt -135.99 146.71 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -140.49 140.18 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 C-N-CA 123.253 0.621 . . . . 0.0 111.977 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.88 168.09 25.36 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.919 0.487 . . . . 0.0 110.523 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -72.14 -18.42 61.89 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.757 0.423 . . . . 0.0 111.339 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -155.57 164.05 39.16 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.745 0.418 . . . . 0.0 111.179 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -73.05 -16.87 61.48 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 122.182 0.193 . . . . 0.0 111.304 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -71.11 -5.59 32.75 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.189 0.596 . . . . 0.0 111.517 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 -22.24 2.54 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.908 0.483 . . . . 0.0 111.341 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.8 t -74.85 -36.87 62.34 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -71.91 -28.73 63.69 Favored 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 122.348 0.259 . . . . 0.0 111.35 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -71.71 -31.89 67.22 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.181 -0.324 . . . . 0.0 110.203 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.5 -26.5 41.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 122.299 0.239 . . . . 0.0 110.606 177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -70.35 -52.46 22.45 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.815 0.446 . . . . 0.0 110.34 177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.58 -14.06 62.76 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.772 0.429 . . . . 0.0 112.035 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.32 -37.98 36.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.152 0.433 . . . . 0.0 110.957 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.9 t -82.44 -4.77 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 122.881 0.473 . . . . 0.0 110.741 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.4 mmt -100.24 -2.8 32.89 Favored 'General case' 0 N--CA 1.457 -0.118 0 O-C-N 121.863 -0.523 . . . . 0.0 112.289 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 42.1 m -150.23 -25.57 0.25 Allowed 'General case' 0 C--N 1.34 0.157 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.3 mt -115.09 -42.57 3.18 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 118.686 0.675 . . . . 0.0 112.147 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.1 mtp 52.62 10.44 0.14 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.644 1.178 . . . . 0.0 113.019 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.2 tp60 54.56 13.65 0.71 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.008 0.923 . . . . 0.0 111.563 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.6 t -156.66 27.8 0.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.543 -0.723 . . . . 0.0 111.04 -175.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -59.49 143.87 48.79 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 121.78 -0.575 . . . . 0.0 111.326 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -156.74 -30.12 0.09 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.963 0.505 . . . . 0.0 111.682 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -150.77 4.1 0.48 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 78.8 tttt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.543 -1.218 . . . . 0.0 111.227 -177.621 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.558 0.218 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.13 -179.32 48.02 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.825 -0.51 . . . . 0.0 111.825 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.6 p -156.66 172.49 18.5 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 123.562 0.745 . . . . 0.0 110.05 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.15 -1.86 28.25 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 70.6 mtm 54.99 21.41 3.72 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.258 1.023 . . . . 0.0 112.774 -178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -154.4 150.86 28.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.113 0.565 . . . . 0.0 109.938 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.52 155.65 18.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.08 60.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.4 147.19 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.1 m -143.51 159.07 16.93 Favored 'Isoleucine or valine' 0 C--O 1.231 0.095 0 C-N-CA 123.79 0.836 . . . . 0.0 110.408 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -79.93 154.21 28.45 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.263 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -140.52 145.46 36.87 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 56.2 mt -142.4 150.0 18.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 124.775 1.23 . . . . 0.0 108.461 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -144.89 138.16 26.75 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -156.2 153.42 29.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.667 0.387 . . . . 0.0 110.165 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -96.65 149.31 21.94 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.608 0.763 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.8 pt -134.2 139.82 34.18 Favored Pre-proline 0 C--N 1.332 -0.165 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -66.62 152.98 79.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.691 2.261 . . . . 0.0 109.481 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -21.26 33.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -173.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.3 t -74.67 -13.28 60.61 Favored 'General case' 0 CA--C 1.526 0.048 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -102.56 -20.98 14.26 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.528 0.331 . . . . 0.0 110.919 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.8 t -65.9 -29.36 46.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.14 0 O-C-N 121.923 -0.486 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.61 -11.83 73.17 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 119.728 -0.484 . . . . 0.0 112.099 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -92.29 -19.19 22.41 Favored 'General case' 0 N--CA 1.458 -0.063 0 CA-C-N 117.707 0.754 . . . . 0.0 110.788 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 58.8 mt -96.38 -32.78 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 122.635 0.374 . . . . 0.0 111.078 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.0 mt -120.6 -3.89 9.81 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.5 7.11 33.89 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 122.052 -0.405 . . . . 0.0 113.715 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 HD21 HG23 ' A' ' 32' ' ' VAL . 16.1 p30 -143.68 50.54 1.36 Allowed 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 117.732 0.766 . . . . 0.0 111.107 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 57.38 29.66 17.27 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.38 0.672 . . . . 0.0 110.574 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 56.62 26.79 11.58 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.783 1.233 . . . . 0.0 113.119 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.45 -25.67 67.38 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.076 -0.39 . . . . 0.0 111.229 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.408 HG23 HD21 ' A' ' 28' ' ' ASN . 19.4 t -74.41 -39.57 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -70.24 -40.01 74.69 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -68.49 -23.31 64.55 Favored 'General case' 0 C--O 1.231 0.084 0 C-N-CA 123.361 0.664 . . . . 0.0 112.349 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -80.5 -37.27 32.03 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 118.122 0.419 . . . . 0.0 110.676 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -69.69 -28.41 37.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -68.23 -23.39 64.8 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 122.174 -0.329 . . . . 0.0 111.066 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -96.22 -17.01 21.09 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.067 0.547 . . . . 0.0 111.501 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -79.17 -28.4 42.71 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.525 0.73 . . . . 0.0 111.129 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -129.4 7.46 5.37 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.332 1.604 . . . . 0.0 115.332 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 56.78 16.94 2.93 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.991 0.916 . . . . 0.0 112.269 -176.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 25.8 p -87.62 -177.83 5.96 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.701 0.8 . . . . 0.0 110.381 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.6 t -132.58 143.41 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.4 mt -132.76 140.38 47.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 m -136.61 106.97 6.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.7 t -79.23 148.64 5.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.031 175.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -127.92 63.69 1.39 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.115 0.566 . . . . 0.0 110.765 -175.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.3 -12.62 14.32 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 115.741 1.756 . . . . 0.0 115.741 -179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.8 -12.36 60.37 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.357 0.263 . . . . 0.0 110.608 176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.8 t -93.34 155.8 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 C-N-CA 123.559 0.744 . . . . 0.0 110.718 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -145.68 129.13 16.93 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.7 p -78.06 -175.3 4.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.395 177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.4 t -67.63 -7.61 27.99 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.942 0.497 . . . . 0.0 110.406 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.331 5.4 p90 -124.42 11.26 8.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.19 2.91 90.69 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.517 -0.601 . . . . 0.0 113.771 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.23 162.16 28.95 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.311 1.055 . . . . 0.0 110.938 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.3 m -116.85 131.44 23.93 Favored Pre-proline 0 C--O 1.231 0.088 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -82.71 161.79 16.48 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.934 3.089 . . . . 0.0 111.17 175.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 p -145.65 147.67 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -116.63 154.79 29.9 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.229 1.012 . . . . 0.0 110.618 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -139.53 147.56 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.574 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -140.57 142.11 31.32 Favored 'Isoleucine or valine' 0 C--N 1.337 0.058 0 C-N-CA 123.417 0.687 . . . . 0.0 110.824 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.17 173.16 16.17 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.721 0.808 . . . . 0.0 109.246 174.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -67.76 -24.79 65.38 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -158.93 172.6 17.9 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.435 0.294 . . . . 0.0 111.52 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.53 -19.59 65.32 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.71 0.404 . . . . 0.0 111.338 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.14 -2.99 20.66 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.865 0.466 . . . . 0.0 111.542 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -130.3 -29.67 2.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.374 0.67 . . . . 0.0 111.106 177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.2 t -75.86 -39.05 57.28 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -73.03 -32.12 64.89 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 117.697 0.226 . . . . 0.0 110.901 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -69.73 -32.48 71.07 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.01 -24.35 40.89 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 121.999 0.12 . . . . 0.0 111.212 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 50.3 ttt-85 -73.0 -49.93 26.1 Favored 'General case' 0 C--N 1.34 0.153 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -70.36 -14.14 62.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.129 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.97 38.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.904 0.482 . . . . 0.0 111.36 175.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.1 t -127.88 -16.87 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.819 0.448 . . . . 0.0 111.714 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.0 mmt -85.85 -7.07 58.95 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -158.57 -37.73 0.06 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -82.69 -41.46 19.31 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 118.129 0.422 . . . . 0.0 111.435 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 50.43 23.56 1.3 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.615 1.166 . . . . 0.0 112.422 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 54.92 12.36 0.59 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.768 1.227 . . . . 0.0 112.263 -173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 41.4 t -95.27 -24.08 16.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.443 0.697 . . . . 0.0 110.33 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -82.55 11.11 6.08 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.937 0.895 . . . . 0.0 111.079 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -67.91 -5.48 17.1 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -137.33 4.1 2.64 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.539 -1.219 . . . . 0.0 110.344 175.68 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 120.307 0.098 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.22 -178.65 42.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -150.26 8.0 0.61 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.765 0.426 . . . . 0.0 111.348 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -142.34 154.26 44.52 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 123.39 0.676 . . . . 0.0 110.511 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -81.34 0.31 37.78 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.136 0.574 . . . . 0.0 112.302 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.4 mttm 54.8 28.07 9.8 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.323 1.049 . . . . 0.0 113.543 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.09 157.82 21.22 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.5 t -83.27 -0.38 49.32 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 122.962 0.505 . . . . 0.0 110.41 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.1 t -66.1 143.65 15.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 O-C-N 121.762 -0.586 . . . . 0.0 111.413 -178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 158.18 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.073 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -78.38 150.2 33.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.603 175.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -141.5 155.7 45.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.355 0.597 . . . . 0.0 112.179 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.4 mt -141.86 153.49 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 125.344 1.458 . . . . 0.0 107.596 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -143.61 133.79 24.39 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -153.31 148.18 26.48 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.842 0.354 . . . . 0.0 111.147 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -94.26 151.44 19.44 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.816 0.847 . . . . 0.0 110.826 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -139.13 135.36 17.32 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.79 154.9 72.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.728 2.286 . . . . 0.0 109.607 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -20.98 42.95 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -77.7 -10.4 59.51 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -108.78 -15.31 14.42 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.34 0.656 . . . . 0.0 111.352 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.8 -29.51 45.3 Favored 'Isoleucine or valine' 0 C--O 1.23 0.054 0 CA-C-N 117.96 0.345 . . . . 0.0 110.457 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.64 -15.14 75.44 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 119.724 -0.487 . . . . 0.0 111.903 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -87.71 -0.44 56.9 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-N 118.095 0.948 . . . . 0.0 111.454 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.9 -34.68 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 117.7 0.227 . . . . 0.0 111.27 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.5 mt -117.86 1.74 12.13 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.14 0.576 . . . . 0.0 112.049 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.65 2.48 67.76 Favored Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.436 -175.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -145.85 67.47 1.2 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.242 1.021 . . . . 0.0 109.889 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.3 mtm-85 53.71 25.18 4.82 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 123.351 0.66 . . . . 0.0 112.137 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.73 24.57 4.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.405 1.082 . . . . 0.0 112.472 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.14 -23.43 67.32 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.93 -0.481 . . . . 0.0 110.841 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 69.1 t -73.46 -37.37 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.64 -41.89 74.99 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -71.73 -13.11 61.62 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 122.939 0.495 . . . . 0.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -81.38 -34.35 31.72 Favored 'General case' 0 C--O 1.228 -0.077 0 CA-C-N 118.529 0.604 . . . . 0.0 110.483 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.8 mt -71.76 -31.06 40.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.07 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.32 -25.03 65.82 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 122.199 0.199 . . . . 0.0 111.468 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -94.1 -17.23 23.03 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.979 0.512 . . . . 0.0 111.514 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -78.93 -29.48 44.15 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.174 0.59 . . . . 0.0 111.383 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -128.06 7.84 6.09 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 56.51 17.09 2.81 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.978 0.911 . . . . 0.0 112.353 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 30.6 p -89.77 -177.19 5.19 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.852 0.861 . . . . 0.0 110.21 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.31 146.79 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 140.11 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 m -135.33 125.06 25.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -176.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 p -79.62 155.53 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -135.93 56.24 1.83 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.607 0.763 . . . . 0.0 110.58 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -60.99 -13.11 13.99 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -73.19 -13.83 61.24 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.448 0.299 . . . . 0.0 110.705 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -90.31 155.08 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 123.495 0.718 . . . . 0.0 110.934 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -147.47 121.34 9.33 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.567 0.347 . . . . 0.0 110.106 177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.5 p -79.61 179.77 7.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.119 0.568 . . . . 0.0 110.856 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.1 p -71.38 0.18 8.77 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.973 0.509 . . . . 0.0 111.031 177.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.338 5.9 p90 -128.86 11.18 6.07 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.02 0.53 88.94 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 119.328 -0.706 . . . . 0.0 113.82 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.71 163.11 27.82 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 118.471 1.136 . . . . 0.0 111.087 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.1 m -118.49 131.24 24.34 Favored Pre-proline 0 C--O 1.231 0.101 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -80.78 156.45 20.92 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.62 2.88 . . . . 0.0 110.994 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.0 t -139.5 148.66 23.16 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 C-N-CA 124.195 0.998 . . . . 0.0 109.492 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -119.23 156.46 29.87 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.157 0.583 . . . . 0.0 111.51 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mt -133.92 148.25 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.2 t -139.74 139.2 38.26 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.096 0 C-N-CA 123.107 0.563 . . . . 0.0 112.17 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.13 169.65 22.87 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.143 0.577 . . . . 0.0 110.07 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -75.81 -14.0 60.29 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 111.56 0.208 . . . . 0.0 111.56 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -157.35 162.93 39.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.84 0.456 . . . . 0.0 111.084 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -73.91 -16.76 61.1 Favored 'General case' 0 CA--C 1.528 0.122 0 O-C-N 122.278 -0.264 . . . . 0.0 111.579 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -70.42 -8.4 50.59 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 123.082 0.553 . . . . 0.0 111.792 -178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -127.92 -21.31 3.7 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 122.847 0.459 . . . . 0.0 111.069 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.5 t -76.03 -39.37 55.77 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -69.86 -34.99 74.33 Favored 'General case' 0 C--O 1.23 0.056 0 C-N-CA 122.066 0.146 . . . . 0.0 110.685 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.81 -30.65 68.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.99 -22.11 49.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.132 0.173 . . . . 0.0 111.347 177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -80.44 -47.86 13.72 Favored 'General case' 0 C--N 1.342 0.239 0 O-C-N 121.938 -0.477 . . . . 0.0 109.805 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -72.35 -15.42 61.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.519 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.45 -4.28 50.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.627 0.371 . . . . 0.0 111.3 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.57 -11.96 11.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.331 0.652 . . . . 0.0 110.995 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 38.8 mmt -82.62 -11.51 58.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.3 t -158.71 -37.17 0.06 Allowed 'General case' 0 C--O 1.231 0.099 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.0 mt -79.21 -43.82 23.08 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 117.922 0.328 . . . . 0.0 110.319 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 65.5 mtp 57.31 -5.9 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.282 1.833 . . . . 0.0 114.662 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.8 mm-40 52.02 19.71 1.08 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.523 1.129 . . . . 0.0 113.178 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 93.6 p -74.12 -8.44 56.18 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.241 0.616 . . . . 0.0 111.729 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -144.57 156.96 44.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.946 0.898 . . . . 0.0 110.447 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -140.35 1.35 1.77 Allowed 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.09 0.556 . . . . 0.0 111.215 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -87.24 12.35 12.0 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.1 mttp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.116 -1.421 . . . . 0.0 109.985 -176.252 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.0 p . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.8 179.59 48.82 Favored Glycine 0 C--N 1.336 0.544 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.9 t -155.93 155.66 33.22 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.129 0.572 . . . . 0.0 110.571 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -68.89 -9.53 52.16 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.665 0.386 . . . . 0.0 111.381 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.0 tpp -73.72 -18.15 61.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.201 0.6 . . . . 0.0 110.928 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -68.02 146.91 53.08 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 122.846 0.458 . . . . 0.0 110.36 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.58 166.12 15.56 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.6 t -139.45 10.47 2.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.721 0.808 . . . . 0.0 109.049 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.7 147.91 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 C-N-CA 123.053 0.541 . . . . 0.0 111.727 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 m -149.1 158.54 6.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.79 156.57 28.73 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.501 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -143.5 150.35 38.82 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.238 0.615 . . . . 0.0 112.145 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -144.43 151.17 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.865 1.266 . . . . 0.0 107.992 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -143.71 138.21 28.71 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -155.85 148.27 23.75 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 122.217 0.207 . . . . 0.0 110.73 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -94.52 148.74 21.94 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.759 0.824 . . . . 0.0 110.829 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.9 pt -136.75 146.3 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -66.23 156.81 63.1 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.276 2.65 . . . . 0.0 110.424 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.61 -25.71 60.47 Favored 'General case' 0 CA--C 1.524 -0.047 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -75.72 -12.69 60.24 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -102.42 -11.21 18.78 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.242 0.617 . . . . 0.0 111.386 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.63 -32.48 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -72.81 -18.72 79.03 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -80.29 -13.95 58.78 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 117.561 0.68 . . . . 0.0 111.255 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.7 mt -106.02 -37.13 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 122.398 0.279 . . . . 0.0 111.008 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 mt -109.76 -8.95 14.85 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -172.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -71.45 -23.18 78.35 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.708 -174.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -93.39 37.4 1.05 Allowed 'General case' 0 CA--C 1.528 0.12 0 CA-C-N 117.398 0.599 . . . . 0.0 110.647 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 56.37 35.03 25.22 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.198 0.523 . . . . 0.0 109.91 -173.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 58.28 20.03 6.84 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.188 1.395 . . . . 0.0 113.747 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.22 -23.26 67.02 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 41.0 t -73.35 -38.2 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -68.34 -41.9 80.05 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -73.16 -13.35 61.15 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.013 0.525 . . . . 0.0 112.181 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -80.91 -28.88 35.68 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 118.272 0.487 . . . . 0.0 110.842 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 89.3 mt -83.02 -29.54 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 122.496 0.319 . . . . 0.0 110.467 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.58 -31.13 70.97 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.304 -0.248 . . . . 0.0 111.415 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -89.24 -13.13 38.87 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 122.169 0.188 . . . . 0.0 111.233 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -81.48 -28.78 33.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.083 0.553 . . . . 0.0 111.179 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -130.26 7.34 4.99 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -176.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 57.86 16.85 3.86 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.106 0.962 . . . . 0.0 112.28 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 84.7 m -89.48 178.59 6.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.02 0.928 . . . . 0.0 110.784 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 84.9 t -129.74 145.4 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.5 mt -132.95 143.7 38.72 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 122.435 0.294 . . . . 0.0 110.277 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -139.2 111.95 7.81 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.98 146.04 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -129.18 70.32 1.41 Allowed 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 -176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -64.14 -6.72 7.06 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -71.72 -20.08 61.96 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.8 0.44 . . . . 0.0 109.873 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -95.26 154.89 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.181 0.992 . . . . 0.0 111.54 -176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -147.04 120.43 9.01 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.3 p -76.38 180.0 5.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.474 0.71 . . . . 0.0 111.097 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m -71.25 1.44 6.08 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.639 0.376 . . . . 0.0 111.291 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.322 6.0 p90 -129.8 11.35 5.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 116.042 1.867 . . . . 0.0 116.042 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.06 -1.1 89.28 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 119.352 -0.693 . . . . 0.0 113.731 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.28 163.83 27.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.215 1.008 . . . . 0.0 111.555 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -118.1 132.68 23.61 Favored Pre-proline 0 N--CA 1.454 -0.235 0 N-CA-C 106.09 -1.819 . . . . 0.0 106.09 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.33 159.49 19.99 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.659 2.906 . . . . 0.0 111.306 177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 t -139.26 144.46 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.607 1.163 . . . . 0.0 109.799 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -117.38 155.13 30.13 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 122.945 0.498 . . . . 0.0 111.098 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -137.58 147.19 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -136.52 143.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.117 0 C-N-CA 123.394 0.678 . . . . 0.0 109.841 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.0 167.76 28.51 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.827 0.346 . . . . 0.0 110.875 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 40.6 tp60 -71.75 -27.68 63.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.011 177.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -159.81 161.03 34.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.353 0.661 . . . . 0.0 111.011 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -72.35 -21.01 61.37 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -173.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.2 mp0 -67.99 -1.59 6.06 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.312 0.505 . . . . 0.0 111.395 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -129.18 -26.01 2.65 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.987 0.515 . . . . 0.0 110.56 176.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.4 t -71.32 -37.21 71.76 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -70.49 -33.46 71.25 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -71.05 -31.65 68.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.01 -21.44 50.79 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 119.72 -0.181 . . . . 0.0 111.044 177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -81.03 -50.13 10.05 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.756 0.313 . . . . 0.0 110.451 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -73.14 -14.95 61.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.565 0.346 . . . . 0.0 111.728 -174.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.29 -4.12 43.32 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.548 0.339 . . . . 0.0 110.855 173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.2 t -118.24 -3.91 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 C-N-CA 123.779 0.832 . . . . 0.0 112.157 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.6 mmt -84.14 -11.73 56.13 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 113.032 0.752 . . . . 0.0 113.032 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.7 t -160.37 -38.31 0.05 Allowed 'General case' 0 C--O 1.23 0.075 0 CA-C-N 118.495 0.589 . . . . 0.0 112.586 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -80.65 -43.16 20.88 Favored 'General case' 0 N--CA 1.456 -0.129 0 O-C-N 122.23 -0.294 . . . . 0.0 110.573 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 48.2 mtp 56.08 -2.16 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 126.35 1.86 . . . . 0.0 114.883 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 49.62 29.31 2.98 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.662 0.785 . . . . 0.0 112.603 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 94.0 p -68.52 1.21 3.26 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.556 0.743 . . . . 0.0 112.715 -176.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -140.22 162.58 34.92 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.926 0.89 . . . . 0.0 109.566 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 55.08 30.31 14.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.19 0.596 . . . . 0.0 111.911 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -71.04 -0.58 9.76 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 59.2 tptt . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.548 -1.215 . . . . 0.0 110.026 -179.357 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.7 p . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.786 0.327 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 10.1 86.45 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 119.842 -0.421 . . . . 0.0 112.839 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.0 t -66.38 161.73 21.93 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 117.644 0.722 . . . . 0.0 111.351 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.0 p-80 -61.58 -13.65 23.51 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.906 0.882 . . . . 0.0 112.265 -178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 72.8 mtm -84.06 -2.92 57.61 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.604 0.362 . . . . 0.0 111.808 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -134.37 18.01 3.68 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.125 0.57 . . . . 0.0 112.49 -176.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.54 152.47 21.92 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.7 p -70.18 -6.7 36.25 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.82 145.9 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 122.762 0.425 . . . . 0.0 110.001 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 m -140.15 153.19 22.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-O 121.373 0.606 . . . . 0.0 109.876 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -85.85 160.22 19.5 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.84 0.856 . . . . 0.0 111.147 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.59 151.45 41.54 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.128 0.571 . . . . 0.0 112.455 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.7 mt -143.64 148.67 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.953 1.301 . . . . 0.0 107.681 176.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -144.6 131.74 20.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -154.4 148.79 26.13 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.708 0.403 . . . . 0.0 110.928 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -89.67 149.84 22.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.827 0.851 . . . . 0.0 111.368 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.14 144.32 49.56 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -63.85 144.96 89.86 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.407 2.071 . . . . 0.0 109.848 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . 0.252 0.2 OUTLIER -62.56 -10.73 13.04 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -178.329 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -73.35 -7.8 53.14 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -135.41 8.67 3.4 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.97 -23.73 34.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.34 -10.55 63.03 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.781 -0.455 . . . . 0.0 112.161 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.55 -29.67 41.46 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 118.208 1.004 . . . . 0.0 110.189 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.8 mt -91.22 -33.93 6.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 122.818 0.447 . . . . 0.0 110.884 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 mt -117.98 23.07 11.88 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.759 0.824 . . . . 0.0 111.9 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.7 1.65 36.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.085 0.374 . . . . 0.0 113.096 -177.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 30' ' ' ALA . 37.9 t-20 -155.06 -154.95 0.53 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -70.25 36.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.557 0.743 . . . . 0.0 110.723 173.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 28' ' ' ASN . . . 55.55 25.62 8.15 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.847 1.259 . . . . 0.0 112.34 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.142 -0.349 . . . . 0.0 111.052 -179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.4 t -73.09 -37.32 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -71.1 -41.6 70.39 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -67.01 -22.98 65.88 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.604 0.761 . . . . 0.0 111.961 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -73.14 -36.86 66.75 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.832 0.287 . . . . 0.0 110.272 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -73.27 -27.01 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.12 -39.72 75.29 Favored 'General case' 0 N--CA 1.457 -0.097 0 O-C-N 122.124 -0.36 . . . . 0.0 111.913 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 ptm85 -83.04 -12.9 56.79 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 122.121 -0.362 . . . . 0.0 110.921 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -79.93 -28.14 39.76 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.103 0.561 . . . . 0.0 111.178 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -127.09 8.58 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 -178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 57.84 16.16 3.45 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.254 1.022 . . . . 0.0 112.812 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.6 p -94.58 -174.72 3.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.729 0.812 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.3 t -134.11 147.81 30.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 60.2 mt -133.84 142.72 40.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 m -136.58 118.51 15.25 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 t -86.81 151.0 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 122.408 0.283 . . . . 0.0 110.35 175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.65 60.35 1.7 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.095 0.558 . . . . 0.0 111.43 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.22 -11.31 14.05 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.1 pm0 -73.34 -11.34 60.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 122.306 -0.246 . . . . 0.0 110.346 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.8 t -96.06 153.04 3.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 C-N-CA 123.894 0.878 . . . . 0.0 110.586 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -148.19 122.42 9.58 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 85.3 p -79.14 173.64 12.37 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.213 0.605 . . . . 0.0 111.112 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 88.4 p -75.81 4.52 7.84 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.106 0.563 . . . . 0.0 110.576 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.335 7.3 p90 -124.97 10.68 8.24 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 116.649 2.092 . . . . 0.0 116.649 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.13 30.25 51.37 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.956 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.1 167.3 11.29 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.54 0.67 . . . . 0.0 111.974 -178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.7 m -128.36 134.24 26.04 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.71 157.21 21.4 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.515 2.81 . . . . 0.0 111.16 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 t -138.43 144.89 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.158 0.983 . . . . 0.0 110.835 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -119.28 153.92 34.29 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.228 0.611 . . . . 0.0 111.198 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.47 146.46 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.18 140.3 40.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.728 0.811 . . . . 0.0 111.113 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -159.11 166.54 31.35 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.303 0.641 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -70.03 -22.19 63.12 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 122.408 -0.182 . . . . 0.0 110.932 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -157.68 166.99 31.35 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.166 0.587 . . . . 0.0 111.257 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.54 -17.98 63.62 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.25 0.22 . . . . 0.0 111.476 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -69.1 -9.81 54.5 Favored 'General case' 0 C--O 1.23 0.053 0 C-N-CA 122.916 0.487 . . . . 0.0 111.415 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -126.4 -22.74 3.94 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.097 0.559 . . . . 0.0 111.136 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.0 t -75.46 -38.11 59.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 118.263 0.483 . . . . 0.0 109.928 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.4 mm-40 -72.57 -27.24 62.07 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -71.52 -33.97 69.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.05 -28.41 43.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.112 0.165 . . . . 0.0 110.662 177.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -66.91 -51.79 51.0 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 122.653 0.381 . . . . 0.0 109.979 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -68.94 -13.39 62.41 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.72 -36.21 23.86 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 122.1 -0.375 . . . . 0.0 111.114 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.3 t -81.62 -7.8 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 O-C-N 121.938 -0.476 . . . . 0.0 109.768 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.3 mmt -98.99 0.41 43.83 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.7 t -156.82 -28.27 0.09 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.4 mt -102.4 -46.73 4.7 Favored 'General case' 0 C--N 1.339 0.12 0 CA-C-N 118.313 0.506 . . . . 0.0 111.714 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 66.1 mtp 50.81 19.49 0.63 Allowed 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.556 1.143 . . . . 0.0 112.127 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 57.13 4.19 0.18 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.849 1.26 . . . . 0.0 112.873 -174.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 92.5 p -89.03 -15.72 33.38 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 123.425 0.69 . . . . 0.0 110.523 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -90.13 157.75 17.6 Favored 'General case' 0 N--CA 1.458 -0.067 0 C-N-CA 123.305 0.642 . . . . 0.0 111.507 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.38 14.92 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.367 0.667 . . . . 0.0 110.791 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -148.49 39.32 0.89 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.592 -1.195 . . . . 0.0 110.984 -179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 120.299 0.095 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.84 179.13 48.54 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.4 m -145.43 163.02 35.94 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.582 0.753 . . . . 0.0 110.552 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -69.98 158.72 35.09 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.162 0.506 . . . . 0.0 111.423 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.9 ttt -149.88 45.34 0.92 Allowed 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.024 0.93 . . . . 0.0 109.105 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt 57.55 21.68 7.35 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.131 0.972 . . . . 0.0 112.237 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.54 152.43 30.32 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 96.5 m -74.05 -7.31 52.01 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.6 t -71.19 143.61 14.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 123.065 0.546 . . . . 0.0 111.606 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.44 159.92 12.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 C-N-CA 123.851 0.86 . . . . 0.0 110.354 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -77.32 154.1 33.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.875 0.47 . . . . 0.0 110.294 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.4 mttt -143.35 144.94 32.28 Favored 'General case' 0 N--CA 1.457 -0.082 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.1 mt -143.12 151.19 17.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.95 1.3 . . . . 0.0 108.287 176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -142.46 138.41 31.0 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.117 0.567 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -157.52 149.37 22.21 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.71 0.29 . . . . 0.0 111.305 179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 64.3 m95 -93.97 149.1 21.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.879 0.872 . . . . 0.0 111.324 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pt -137.8 147.01 55.18 Favored Pre-proline 0 CA--C 1.529 0.153 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.08 144.1 86.35 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 122.918 2.412 . . . . 0.0 109.945 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.38 -17.51 44.21 Favored 'General case' 0 N--CA 1.459 0.013 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -176.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 t -77.83 -12.57 59.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -105.89 -9.01 17.36 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.493 0.317 . . . . 0.0 111.447 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.97 -24.43 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 121.906 -0.496 . . . . 0.0 109.675 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.64 -15.18 70.7 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-O 119.525 -0.597 . . . . 0.0 111.985 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -83.95 -24.05 30.83 Favored 'General case' 0 N--CA 1.457 -0.097 0 CA-C-N 118.483 1.142 . . . . 0.0 111.002 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mt -92.85 -33.73 5.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 119.681 -0.2 . . . . 0.0 111.179 -177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -120.14 -0.09 10.58 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 113.383 0.882 . . . . 0.0 113.383 -172.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.93 4.54 45.33 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.9 -0.389 . . . . 0.0 113.865 -174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 ' CG1' ' A' ' 32' ' ' VAL . 23.1 p30 -145.62 51.89 1.18 Allowed 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.682 0.741 . . . . 0.0 111.183 -177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.5 mmt85 56.5 31.72 19.45 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.106 0.563 . . . . 0.0 110.788 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.87 30.55 16.1 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.354 1.062 . . . . 0.0 113.207 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.66 -34.23 71.01 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.143 -0.348 . . . . 0.0 111.169 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' CG1' HD21 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -73.01 -34.64 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -69.93 -43.35 71.8 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -68.76 -23.22 64.3 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 122.473 0.309 . . . . 0.0 111.525 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.5 -38.99 67.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.5 mt -70.14 -30.03 42.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 O-C-N 122.134 -0.354 . . . . 0.0 110.275 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -68.81 -32.48 72.22 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -90.0 -12.95 37.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.469 0.577 . . . . 0.0 110.703 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -80.33 -28.64 38.1 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.388 0.675 . . . . 0.0 111.023 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -127.26 6.03 6.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 57.47 16.48 3.29 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.313 1.045 . . . . 0.0 112.533 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 29.9 p -88.79 -176.98 5.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 123.694 0.798 . . . . 0.0 110.418 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -133.15 143.48 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.2 mt -132.43 144.54 36.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-O 120.756 0.313 . . . . 0.0 110.35 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -135.36 137.81 42.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 t -109.11 147.55 13.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 122.542 0.337 . . . . 0.0 110.486 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -127.15 58.16 1.45 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.078 0.551 . . . . 0.0 111.573 -173.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -11.44 15.77 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.8 pm0 -73.48 -13.68 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.266 0.227 . . . . 0.0 110.448 176.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.0 t -79.94 156.43 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.214 0.606 . . . . 0.0 109.723 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -147.34 132.63 18.47 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 69.6 m -132.23 157.06 45.34 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.538 0.735 . . . . 0.0 110.61 176.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -66.96 -17.48 64.94 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.332 2.1 p90 -81.35 1.28 33.5 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 177.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 43.19 60.46 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.642 -0.532 . . . . 0.0 112.579 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.19 166.44 23.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 117.448 0.624 . . . . 0.0 111.736 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -131.37 132.89 23.87 Favored Pre-proline 0 N--CA 1.455 -0.177 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -80.31 155.87 22.23 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.384 2.722 . . . . 0.0 111.728 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.64 158.12 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.287 1.035 . . . . 0.0 111.985 175.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -131.64 154.06 49.31 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.487 0.715 . . . . 0.0 110.895 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.6 mt -139.18 147.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 123.416 0.686 . . . . 0.0 109.417 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -141.89 143.01 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 C-N-CA 123.703 0.801 . . . . 0.0 110.104 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.18 168.85 24.5 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.102 0.561 . . . . 0.0 109.969 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.24 -18.64 58.93 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -147.67 155.4 41.72 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 123.02 0.528 . . . . 0.0 110.848 -176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -68.35 -23.06 64.65 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.552 0.341 . . . . 0.0 110.122 174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -70.48 -4.34 22.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.27 0.628 . . . . 0.0 111.58 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -125.04 -29.5 3.32 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.747 0.419 . . . . 0.0 111.079 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.8 t -75.31 -38.02 60.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -72.06 -30.03 64.74 Favored 'General case' 0 C--N 1.339 0.132 0 O-C-N 122.526 -0.109 . . . . 0.0 111.181 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -72.26 -32.38 66.61 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.23 -178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -79.68 -28.06 40.74 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.281 0.232 . . . . 0.0 110.375 176.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.2 tpt85 -71.29 -43.16 67.66 Favored 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.477 0.711 . . . . 0.0 110.744 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -77.34 -15.94 59.15 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.25 53.01 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.508 0.594 . . . . 0.0 111.775 178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 72.1 t -82.42 -10.72 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 121.971 -0.456 . . . . 0.0 110.889 -176.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.0 mmt -88.88 -11.62 44.1 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 97.6 p -152.9 -20.02 0.16 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.17 -40.76 5.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 119.262 0.937 . . . . 0.0 111.112 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 57.7 mtp 51.28 16.52 0.4 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.497 1.119 . . . . 0.0 112.823 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 41.2 tp60 52.8 23.97 3.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.123 0.969 . . . . 0.0 111.962 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 89.6 p -147.69 -9.7 0.41 Allowed 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -77.77 152.34 33.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.791 0.723 . . . . 0.0 110.72 178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -77.59 -13.09 60.0 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -86.36 2.27 48.1 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.206 178.852 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.43 160.24 24.95 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 t -70.2 151.12 45.74 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -141.58 156.89 45.66 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.085 0.954 . . . . 0.0 110.399 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 27.4 ttt -73.45 -22.9 60.07 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.617 0.367 . . . . 0.0 111.32 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -74.07 158.73 33.74 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 120.983 0.421 . . . . 0.0 110.827 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.68 162.93 22.6 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 88.9 m -128.42 6.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.596 0.758 . . . . 0.0 110.853 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.88 149.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 122.958 0.503 . . . . 0.0 111.894 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.7 m -144.83 156.78 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 C-N-CA 123.77 0.828 . . . . 0.0 110.282 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -82.88 158.62 22.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.074 0.55 . . . . 0.0 110.589 177.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -145.76 149.09 33.73 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.878 0.471 . . . . 0.0 112.035 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.7 mt -143.97 150.14 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 124.628 1.171 . . . . 0.0 108.458 176.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -142.81 137.13 29.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.108 0.563 . . . . 0.0 109.679 176.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.91 149.65 21.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.83 0.348 . . . . 0.0 110.785 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -89.75 147.9 23.56 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.95 0.9 . . . . 0.0 111.08 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.36 147.65 62.91 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.15 141.97 78.43 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.109 2.539 . . . . 0.0 109.798 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -17.25 40.06 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 115.807 1.78 . . . . 0.0 115.807 -177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.9 t -76.48 -13.18 60.12 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -109.04 -6.39 15.66 Favored 'General case' 0 C--N 1.338 0.085 0 C-N-CA 122.782 0.433 . . . . 0.0 111.391 179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.8 -25.62 38.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.33 -9.85 65.05 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 119.655 -0.525 . . . . 0.0 112.269 178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -87.15 -27.38 23.09 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 118.107 0.954 . . . . 0.0 109.876 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.2 mt -89.06 -33.57 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.725 0.41 . . . . 0.0 110.649 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 42.5 mt -118.77 16.07 13.54 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.05 0.94 . . . . 0.0 112.239 -173.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.04 -17.79 66.02 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.555 -0.58 . . . . 0.0 114.153 -173.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -158.5 98.07 1.51 Allowed 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 118.074 0.937 . . . . 0.0 110.522 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 51.07 23.95 1.73 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 123.709 0.804 . . . . 0.0 112.892 177.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.66 24.36 4.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.022 0.929 . . . . 0.0 112.64 -175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.15 -24.32 67.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.857 -0.527 . . . . 0.0 111.685 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.21 -37.3 51.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -69.52 -41.32 76.16 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -67.49 -23.37 65.47 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 123.362 0.665 . . . . 0.0 111.891 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -74.4 -33.69 63.09 Favored 'General case' 0 N--CA 1.456 -0.145 0 CA-C-N 118.086 0.403 . . . . 0.0 110.719 177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.46 -30.47 34.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.07 -29.17 68.06 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.329 0.252 . . . . 0.0 111.214 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -87.14 -15.6 37.92 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.677 0.391 . . . . 0.0 111.462 177.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -81.58 -29.47 33.36 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.264 0.625 . . . . 0.0 111.395 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -129.72 7.86 5.27 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 57.53 15.25 2.67 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.137 0.975 . . . . 0.0 112.616 -176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -87.38 -176.42 5.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.71 0.804 . . . . 0.0 110.375 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.3 t -133.06 145.07 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.125 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 79.3 mt -133.13 145.26 34.33 Favored 'Isoleucine or valine' 0 C--O 1.229 0.015 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -134.93 139.96 45.36 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.1 t -111.64 147.01 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.12 0 C-N-CA 122.435 0.294 . . . . 0.0 110.78 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -127.76 56.76 1.56 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.39 0.676 . . . . 0.0 111.791 -172.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -62.17 -11.0 12.11 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.9 pm0 -73.71 -12.98 60.89 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.363 0.265 . . . . 0.0 110.599 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.0 t -80.27 155.83 4.47 Favored 'Isoleucine or valine' 0 C--N 1.339 0.112 0 C-N-CA 123.011 0.525 . . . . 0.0 109.856 175.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -146.61 127.04 14.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.77 0.319 . . . . 0.0 110.157 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 73.6 m -130.08 155.61 45.88 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.493 0.717 . . . . 0.0 110.749 177.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.1 m -67.12 -17.07 64.7 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 123.004 0.521 . . . . 0.0 112.295 -175.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.34 2.2 p90 -82.2 1.05 38.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.46 44.78 49.87 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.793 -0.448 . . . . 0.0 112.346 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -138.7 168.29 20.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 117.337 0.569 . . . . 0.0 111.991 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.5 m -133.88 133.49 22.26 Favored Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.04 154.08 22.35 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 123.319 2.68 . . . . 0.0 111.323 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.5 157.8 41.51 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 123.905 0.882 . . . . 0.0 111.593 175.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -130.11 154.48 47.44 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.461 0.704 . . . . 0.0 110.905 -176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.9 mt -137.98 147.98 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.027 0 C-N-CA 123.501 0.721 . . . . 0.0 109.571 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.6 t -140.29 140.66 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 123.545 0.738 . . . . 0.0 110.398 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.48 167.78 26.49 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.167 0.587 . . . . 0.0 110.081 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -73.59 -17.26 61.2 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 122.415 -0.178 . . . . 0.0 111.349 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.54 165.16 35.19 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 120.939 0.4 . . . . 0.0 111.041 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -72.08 -16.2 62.02 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.036 -0.415 . . . . 0.0 110.999 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -71.02 -3.49 19.87 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.111 0.565 . . . . 0.0 111.315 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -131.48 -26.18 2.08 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.032 0.533 . . . . 0.0 111.175 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.6 t -74.43 -38.0 63.14 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.24 -29.97 61.95 Favored 'General case' 0 N--CA 1.456 -0.158 0 O-C-N 122.499 -0.126 . . . . 0.0 110.937 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -73.17 -31.82 64.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.71 -23.89 45.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.527 0.331 . . . . 0.0 111.02 177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -73.13 -53.0 12.13 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 122.969 0.508 . . . . 0.0 110.066 176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -67.57 -13.0 61.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.819 0.448 . . . . 0.0 112.143 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.45 -4.56 59.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.97 0.508 . . . . 0.0 112.166 176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.0 t -124.72 -7.0 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.4 mmt -80.19 -16.37 54.98 Favored 'General case' 0 C--O 1.231 0.086 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.0 t -159.75 -36.56 0.06 Allowed 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 118.189 0.449 . . . . 0.0 111.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.5 mt -74.03 -43.66 57.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 50.6 mtp 50.02 21.26 0.7 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 53.41 24.03 3.71 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.243 1.017 . . . . 0.0 111.152 -175.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.7 m -132.79 -1.28 3.39 Favored 'General case' 0 C--N 1.34 0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 111.406 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -130.22 10.24 5.32 Favored 'General case' 0 C--N 1.338 0.101 0 C-N-CA 123.884 0.874 . . . . 0.0 111.592 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -65.37 -17.95 64.93 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.609 0.364 . . . . 0.0 111.591 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.1 p30 -79.61 1.42 26.19 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.447 -1.264 . . . . 0.0 110.893 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 95.3 p . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.65 0.262 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.62 -15.37 80.62 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 112.059 -0.416 . . . . 0.0 112.059 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.8 p -77.66 -6.47 53.97 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.643 0.722 . . . . 0.0 111.452 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 28.0 m80 58.91 170.66 0.06 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.834 1.254 . . . . 0.0 113.2 -177.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -73.09 -8.5 56.02 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.309 0.644 . . . . 0.0 111.19 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -154.69 147.97 24.94 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.31 0.644 . . . . 0.0 109.587 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 139.79 58.06 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 115.738 1.755 . . . . 0.0 115.738 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.2 p -78.1 -3.64 43.34 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 p -67.89 148.65 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 m -142.65 153.47 17.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 123.159 0.584 . . . . 0.0 110.631 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -89.86 160.32 16.53 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.872 0.869 . . . . 0.0 110.622 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -142.82 149.51 38.7 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 123.233 0.613 . . . . 0.0 112.437 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 73.7 mt -144.35 152.34 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.722 1.209 . . . . 0.0 108.163 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -140.85 140.0 34.55 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.841 0.457 . . . . 0.0 110.118 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -158.22 152.28 24.06 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.512 0.196 . . . . 0.0 111.002 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 64.0 m95 -97.47 153.53 18.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.921 0.888 . . . . 0.0 111.543 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 pt -141.0 137.71 17.26 Favored Pre-proline 0 N--CA 1.455 -0.178 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.42 144.31 85.09 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 122.834 2.356 . . . . 0.0 109.748 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.67 -12.91 7.8 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -176.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 t -75.94 -6.66 51.94 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -138.35 8.14 2.65 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.976 -0.453 . . . . 0.0 112.189 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.0 -25.64 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.7 -13.59 68.96 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -77.22 -8.0 56.84 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 117.981 0.89 . . . . 0.0 111.093 177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.1 mt -117.99 -27.05 2.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.178 0 C-N-CA 122.762 0.425 . . . . 0.0 111.26 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 mt -116.29 -4.33 11.88 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.22 -21.25 70.79 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -96.13 34.01 1.64 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.423 0.689 . . . . 0.0 110.561 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 87.8 mtm-85 55.47 32.7 19.49 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 -172.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 59.69 18.49 7.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.175 1.39 . . . . 0.0 113.704 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.97 -32.01 72.42 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 122.033 -0.417 . . . . 0.0 110.141 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -72.09 -33.46 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.077 0.551 . . . . 0.0 109.552 179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -69.83 -42.24 73.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -69.69 -20.07 63.57 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 122.918 0.487 . . . . 0.0 112.246 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -76.32 -30.8 57.84 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.244 0.475 . . . . 0.0 110.591 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.2 mt -73.82 -31.69 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -68.45 -32.57 72.67 Favored 'General case' 0 N--CA 1.458 -0.045 0 C-N-CA 122.619 0.367 . . . . 0.0 110.296 175.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.3 ttt85 -80.18 -22.06 42.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.619 0.768 . . . . 0.0 111.191 177.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -82.21 -30.9 30.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.047 0.539 . . . . 0.0 111.787 -178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -124.54 8.03 8.31 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 57.57 15.19 2.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.104 0.962 . . . . 0.0 112.348 -177.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.5 p -90.21 -174.64 4.26 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.6 0.76 . . . . 0.0 110.165 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.5 t -134.79 146.23 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 174.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.6 mt -133.79 142.7 40.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 122.6 0.36 . . . . 0.0 110.061 -177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 m -137.9 120.71 16.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.1 t -89.98 146.95 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -125.34 64.46 1.16 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.24 0.616 . . . . 0.0 110.995 -175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.2 p -62.73 -12.35 23.32 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -74.89 0.82 14.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.631 0.372 . . . . 0.0 109.997 173.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.2 t -119.87 146.65 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.795 1.238 . . . . 0.0 111.128 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -154.49 119.48 4.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 44.6 t -79.2 165.22 23.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 122.608 0.363 . . . . 0.0 110.632 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 97.4 p -66.59 -16.8 64.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.742 0.417 . . . . 0.0 111.074 -178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.378 2.4 p90 -82.99 6.82 17.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 175.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.74 42.24 32.25 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 112.169 -0.372 . . . . 0.0 112.169 176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 156.33 48.16 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-N 117.415 0.607 . . . . 0.0 112.283 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 m -111.13 134.25 21.12 Favored Pre-proline 0 N--CA 1.454 -0.251 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.1 154.66 19.38 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.497 2.798 . . . . 0.0 111.133 178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.2 157.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.212 1.005 . . . . 0.0 112.366 175.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -128.43 154.36 46.13 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.298 0.639 . . . . 0.0 110.95 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.6 mt -135.75 146.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.55 0.74 . . . . 0.0 109.095 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.74 142.43 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.675 0.79 . . . . 0.0 111.449 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.02 167.61 27.51 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.135 0.574 . . . . 0.0 110.106 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -69.11 -25.0 64.19 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.394 -0.191 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -157.17 170.9 21.44 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.984 0.514 . . . . 0.0 111.188 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -69.95 -24.47 63.35 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 122.056 -0.402 . . . . 0.0 111.721 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.1 mp0 -69.06 -5.48 22.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.012 0.525 . . . . 0.0 112.034 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -126.22 -19.91 4.6 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.073 0.549 . . . . 0.0 111.328 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.4 t -80.87 -38.44 28.13 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 118.272 0.487 . . . . 0.0 109.695 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -72.59 -27.27 62.08 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -69.76 -33.2 72.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.154 -0.341 . . . . 0.0 110.545 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.87 -29.05 32.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 110.386 -0.228 . . . . 0.0 110.386 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.0 tpt85 -67.47 -40.3 85.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 122.626 0.37 . . . . 0.0 110.627 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.12 -10.36 59.76 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 -34.01 21.38 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 118.262 0.483 . . . . 0.0 111.367 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.3 t -79.53 -11.63 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 O-C-N 122.059 -0.401 . . . . 0.0 110.753 -175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 33.5 mmt -84.17 -13.72 52.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.3 m -151.87 -29.02 0.17 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.588 0.959 . . . . 0.0 113.588 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.5 mt -94.72 -44.04 7.98 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-N 118.323 0.511 . . . . 0.0 111.108 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 52.4 mtp 52.31 8.1 0.07 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.309 1.444 . . . . 0.0 112.594 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 43.6 tp60 55.82 13.21 1.02 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.659 1.183 . . . . 0.0 111.834 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 91.0 p -158.45 2.63 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -176.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -68.89 -0.22 5.25 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.99 0.814 . . . . 0.0 111.832 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -71.36 -14.12 62.08 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.037 -0.414 . . . . 0.0 110.638 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . 0.278 64.3 m-20 57.2 10.8 0.92 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 117.012 2.227 . . . . 0.0 117.012 177.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 C--O 1.254 1.29 0 CA-C-O 117.944 -1.026 . . . . 0.0 111.068 178.374 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.7 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 120.619 0.247 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.86 178.43 50.9 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 98.6 p -157.81 168.03 28.33 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.478 0.711 . . . . 0.0 110.475 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -153.16 161.92 41.9 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 122.99 0.516 . . . . 0.0 109.937 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -71.52 -9.81 58.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.89 0.476 . . . . 0.0 112.257 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -143.79 159.43 42.52 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 123.88 0.872 . . . . 0.0 110.057 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.66 156.64 37.79 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 79.0 m -84.19 2.48 39.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.238 0.615 . . . . 0.0 111.657 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 t -70.7 146.77 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 123.132 0.573 . . . . 0.0 111.832 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.9 m -142.9 159.71 18.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 123.527 0.731 . . . . 0.0 110.876 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.3 154.18 33.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.382 0.673 . . . . 0.0 110.141 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -142.66 144.75 32.9 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -144.34 149.54 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.766 1.227 . . . . 0.0 107.865 176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -145.59 138.33 25.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -157.67 156.66 32.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.8 0.44 . . . . 0.0 110.504 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -98.87 146.68 25.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 111.099 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.4 pt -132.28 147.96 67.82 Favored Pre-proline 0 CA--C 1.529 0.145 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -63.03 141.32 83.17 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.278 1.986 . . . . 0.0 109.857 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.45 -16.26 34.56 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 -178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 p -77.6 -10.81 59.71 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -114.98 -2.63 12.79 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 122.826 0.45 . . . . 0.0 111.724 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.98 -23.17 32.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.24 -14.36 74.03 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.644 -0.582 . . . . 0.0 111.644 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -81.06 -16.34 53.5 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 118.409 1.104 . . . . 0.0 110.611 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.5 mt -107.17 -34.81 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 122.841 0.456 . . . . 0.0 111.445 -177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.2 mt -119.33 3.58 11.31 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.62 -0.36 54.05 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.782 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -147.36 59.35 1.16 Allowed 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.15 0.975 . . . . 0.0 111.478 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 56.41 30.99 17.95 Favored 'General case' 0 N--CA 1.461 0.101 0 C-N-CA 123.496 0.718 . . . . 0.0 111.187 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 55.82 26.06 9.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.569 1.148 . . . . 0.0 112.812 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.62 -24.68 67.89 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.958 -0.464 . . . . 0.0 111.217 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 65.6 t -75.75 -37.59 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -68.2 -42.96 79.12 Favored 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -70.52 -16.41 62.88 Favored 'General case' 0 C--O 1.231 0.118 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -76.88 -33.82 57.82 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-N 118.316 0.507 . . . . 0.0 110.389 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.2 mt -71.62 -30.37 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.091 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.11 -26.01 66.49 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.58 0.352 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -92.56 -16.3 25.88 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.044 0.537 . . . . 0.0 110.931 176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.97 -29.14 35.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.512 0.725 . . . . 0.0 111.143 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.14 7.26 5.45 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 -178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 56.81 17.4 3.21 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.901 0.88 . . . . 0.0 112.218 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.8 -176.43 4.95 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.297 1.039 . . . . 0.0 110.129 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.79 145.43 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.087 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 175.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 68.5 mt -133.29 141.53 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 m -138.57 102.34 4.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 114.714 1.376 . . . . 0.0 114.714 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.8 t -76.2 143.72 12.74 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 173.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -123.19 72.26 1.1 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 122.547 0.339 . . . . 0.0 111.387 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -65.18 -4.84 5.55 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -72.55 -4.25 29.52 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.192 0.597 . . . . 0.0 109.671 172.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 t -126.7 146.69 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 C-N-CA 124.433 1.093 . . . . 0.0 111.77 -177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -153.04 120.26 5.85 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.6 t -78.69 163.36 25.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.936 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.2 m -66.21 -16.91 64.39 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.953 0.501 . . . . 0.0 111.113 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.381 2.5 p90 -84.02 7.82 17.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.93 41.38 27.97 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.926 -0.374 . . . . 0.0 112.189 177.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.89 158.93 42.98 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.323 0.561 . . . . 0.0 112.127 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.7 m -121.48 134.78 24.64 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -80.69 159.96 21.81 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 123.526 2.818 . . . . 0.0 111.772 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.32 149.13 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -120.77 156.45 31.82 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 124.14 0.976 . . . . 0.0 110.442 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.3 mt -138.03 148.11 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.5 t -141.21 143.28 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 C-N-CA 123.65 0.78 . . . . 0.0 109.586 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.01 169.95 22.34 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 44.3 tp60 -74.29 -22.2 59.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -148.14 158.93 44.35 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.091 0.557 . . . . 0.0 110.829 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.1 -24.01 66.62 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 122.368 0.267 . . . . 0.0 110.474 173.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.38 -6.19 23.12 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.354 0.662 . . . . 0.0 111.311 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -125.84 -26.0 3.54 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.839 0.456 . . . . 0.0 111.141 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.0 t -80.14 -37.39 33.59 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.51 -30.14 64.23 Favored 'General case' 0 C--N 1.339 0.111 0 O-C-N 122.3 -0.25 . . . . 0.0 110.601 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -73.47 -32.23 64.21 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -77.0 -24.85 52.19 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 122.421 0.288 . . . . 0.0 110.739 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.501 ' HE ' ' HG3' ' A' ' 77' ' ' MET . 13.0 tpt180 -73.29 -51.61 16.96 Favored 'General case' 0 C--N 1.338 0.099 0 C-N-CA 123.237 0.615 . . . . 0.0 110.059 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -69.05 -15.19 63.4 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.73 -4.72 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -120.74 -11.68 9.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 122.874 0.47 . . . . 0.0 111.54 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.501 ' HG3' ' HE ' ' A' ' 73' ' ' ARG . 16.7 mmt -92.52 0.07 57.39 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.5 t -157.92 -40.14 0.07 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.0 mt -86.32 -36.31 19.35 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.616 0.189 . . . . 0.0 111.419 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 42.5 mtp 52.82 10.16 0.14 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.377 1.471 . . . . 0.0 113.448 -179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 51.29 24.93 2.26 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.37 1.068 . . . . 0.0 111.449 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -147.45 17.37 1.17 Allowed 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.886 -0.509 . . . . 0.0 111.284 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -61.43 150.38 35.66 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 122.785 0.434 . . . . 0.0 111.257 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.32 -5.24 38.33 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.346 0.658 . . . . 0.0 111.867 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -70.38 5.49 1.74 Allowed 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 64.4 tttp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.718 -1.134 . . . . 0.0 110.393 -179.386 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.472 0.666 0 CA-C-O 120.55 0.214 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.32 174.91 42.31 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 t -156.9 153.7 28.58 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.827 0.451 . . . . 0.0 110.527 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -68.68 -9.94 53.3 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.778 0.431 . . . . 0.0 111.163 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 52.1 ttp -72.6 -10.84 60.28 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.281 0.632 . . . . 0.0 111.347 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt 52.76 48.83 21.63 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.814 0.845 . . . . 0.0 110.431 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.76 146.88 12.72 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 115.869 1.803 . . . . 0.0 115.869 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 49.1 t -75.41 -13.89 60.42 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.005 0.522 . . . . 0.0 111.363 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.4 t -67.5 138.19 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 O-C-N 122.087 -0.383 . . . . 0.0 111.114 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.6 m -151.23 163.28 2.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.624 1.17 . . . . 0.0 108.644 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -75.16 152.39 38.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -143.85 144.78 31.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.1 mt -144.33 152.04 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.107 1.363 . . . . 0.0 107.925 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -144.41 138.57 27.83 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.448 0.299 . . . . 0.0 110.471 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -155.9 150.18 25.67 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.399 0.279 . . . . 0.0 110.807 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 52' ' ' SER . 65.8 m95 -94.37 149.48 21.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.07 0.948 . . . . 0.0 111.445 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.3 pt -139.09 139.88 24.76 Favored Pre-proline 0 C--N 1.333 -0.137 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -65.87 149.43 86.53 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.374 2.716 . . . . 0.0 110.145 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 p -61.73 -16.37 48.7 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.2 p -66.99 -8.53 30.6 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 175.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -138.86 9.26 2.58 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.26 -24.6 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -68.79 -14.11 67.15 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.821 -0.512 . . . . 0.0 111.821 177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -80.42 -3.02 48.15 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 117.486 0.643 . . . . 0.0 110.782 176.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.0 mt -124.51 -33.56 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 122.647 0.379 . . . . 0.0 111.134 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 45.6 mt -119.05 1.65 11.42 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -174.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -75.75 4.64 43.36 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.552 -0.582 . . . . 0.0 113.437 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.498 HD21 HG23 ' A' ' 32' ' ' VAL . 20.2 p30 -148.06 53.1 1.02 Allowed 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 117.977 0.888 . . . . 0.0 111.309 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 57.01 29.92 17.27 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 122.945 0.498 . . . . 0.0 111.203 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 57.1 24.2 9.39 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.66 1.184 . . . . 0.0 113.062 -178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.13 -26.78 68.98 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.996 -0.44 . . . . 0.0 111.338 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.498 HG23 HD21 ' A' ' 28' ' ' ASN . 12.6 t -78.26 -32.43 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -66.45 -36.99 84.17 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.68 -22.24 62.5 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.171 0.589 . . . . 0.0 111.454 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -73.15 -32.13 64.69 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.057 0.39 . . . . 0.0 110.7 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.51 -30.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -68.72 -33.54 74.11 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptm85 -87.47 -13.19 43.84 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 117.75 0.25 . . . . 0.0 111.09 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -79.89 -29.35 39.89 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.824 0.449 . . . . 0.0 111.213 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -128.65 8.13 5.8 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 56.97 16.57 2.88 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.017 0.927 . . . . 0.0 112.431 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.42 -177.29 5.31 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.861 0.864 . . . . 0.0 110.65 178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.5 t -132.33 145.32 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 175.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.3 mt -132.8 141.94 43.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 C-N-CA 122.793 0.437 . . . . 0.0 109.844 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -138.1 111.87 8.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.6 t -82.04 145.15 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -122.08 69.58 0.95 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.882 0.473 . . . . 0.0 110.701 -176.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 p -63.29 -8.67 9.04 Favored 'General case' 0 C--O 1.23 0.055 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -74.5 2.15 10.29 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.134 0.974 . . . . 0.0 110.384 171.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 t -130.63 149.8 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.82 1.248 . . . . 0.0 111.661 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -152.75 128.51 10.18 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 172.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 16' ' ' TRP . 41.9 t -81.61 167.41 19.27 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.538 176.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.8 p -66.93 -17.41 64.9 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 122.847 0.459 . . . . 0.0 110.784 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . 0.364 2.9 p90 -83.14 5.41 22.72 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 116.565 2.061 . . . . 0.0 116.565 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.06 44.63 35.27 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-O 119.891 -0.394 . . . . 0.0 112.318 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.72 158.65 43.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 117.624 0.712 . . . . 0.0 112.153 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.1 m -104.82 131.96 21.33 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 124.655 1.182 . . . . 0.0 113.446 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -78.75 156.11 27.46 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.897 2.398 . . . . 0.0 110.793 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t -140.0 147.16 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 C-N-CA 124.594 1.158 . . . . 0.0 110.68 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -123.3 155.01 38.07 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 123.33 0.652 . . . . 0.0 110.915 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.9 mt -136.74 147.22 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -140.99 144.15 27.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.062 0 C-N-CA 123.298 0.639 . . . . 0.0 110.518 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -160.54 169.91 21.98 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.215 0.606 . . . . 0.0 110.122 176.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -72.77 -18.87 61.45 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 122.77 0.428 . . . . 0.0 111.604 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -156.45 165.89 35.01 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.036 0.446 . . . . 0.0 111.767 -177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -72.32 -18.91 61.73 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 122.749 0.42 . . . . 0.0 111.1 176.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -67.37 -15.9 63.94 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.683 0.793 . . . . 0.0 111.488 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -125.74 -22.19 4.27 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.468 0.307 . . . . 0.0 111.669 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.4 t -74.3 -36.99 63.77 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -72.85 -28.28 62.43 Favored 'General case' 0 C--N 1.34 0.187 0 O-C-N 122.243 -0.286 . . . . 0.0 111.634 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -70.82 -31.77 68.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 122.141 -0.349 . . . . 0.0 110.16 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -80.67 -28.09 36.92 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.311 0.244 . . . . 0.0 110.733 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -71.18 -41.26 70.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.847 0.459 . . . . 0.0 111.067 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -79.38 -13.47 59.59 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 112.624 0.602 . . . . 0.0 112.624 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.58 -31.77 41.91 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-N 118.372 0.533 . . . . 0.0 111.513 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 66.9 t -83.0 -9.59 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 122.047 -0.408 . . . . 0.0 110.826 -175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 32.9 mmt -85.43 -4.12 59.06 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.9 t -160.03 -38.49 0.05 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-N 118.79 0.723 . . . . 0.0 112.915 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.8 mt -85.99 -46.85 10.14 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 122.097 -0.377 . . . . 0.0 110.847 -177.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 53.0 mtp 55.82 -0.91 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.88 1.672 . . . . 0.0 113.695 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 73.6 mm-40 52.63 17.86 0.89 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.533 1.133 . . . . 0.0 113.649 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.4 t -73.24 -14.24 61.29 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 121.903 -0.498 . . . . 0.0 111.199 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -76.05 -1.49 26.13 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.042 0.537 . . . . 0.0 112.226 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 -75.83 -10.41 59.4 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.19 14.07 0.48 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.691 0.797 . . . . 0.0 112.458 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.6 p . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.411 0.148 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.46 -5.11 85.54 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.965 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 91.1 p -77.25 -10.15 59.24 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.43 1.115 . . . . 0.0 111.417 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.9 m170 -72.89 163.05 28.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.072 0.549 . . . . 0.0 110.753 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.9 ttm -70.07 -23.28 63.05 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.705 0.402 . . . . 0.0 111.233 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.19 141.54 50.68 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.855 0.462 . . . . 0.0 109.947 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.24 154.63 41.69 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.5 m -87.03 3.7 44.93 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.102 0.561 . . . . 0.0 111.69 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.28 140.51 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.084 0 C-N-CA 123.165 0.586 . . . . 0.0 112.347 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 m -145.36 155.47 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 C-N-CA 123.67 0.788 . . . . 0.0 111.303 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -85.32 160.26 19.86 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.538 0.735 . . . . 0.0 110.357 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -144.79 150.59 37.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.085 0.554 . . . . 0.0 112.395 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.2 mt -145.11 150.14 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 124.833 1.253 . . . . 0.0 107.935 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -144.3 137.29 27.1 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.718 0.407 . . . . 0.0 109.991 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -158.51 149.78 20.8 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 122.697 0.399 . . . . 0.0 110.544 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 58.0 m95 -89.41 148.51 23.44 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.933 0.893 . . . . 0.0 111.322 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.19 144.29 49.31 Favored Pre-proline 0 N--CA 1.456 -0.163 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 173.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.37 144.76 91.76 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.014 2.476 . . . . 0.0 110.199 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.11 -19.69 46.86 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.9 t -77.81 -11.6 59.9 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -109.66 -5.88 15.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.594 0.358 . . . . 0.0 111.667 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.63 -24.93 36.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.99 -11.56 74.51 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-O 119.562 -0.577 . . . . 0.0 111.996 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -83.14 -25.72 31.63 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.37 1.085 . . . . 0.0 110.302 175.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 39.1 mt -93.15 -35.33 6.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 C-N-CA 122.877 0.471 . . . . 0.0 111.089 -178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.6 mt -117.56 15.96 14.6 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.702 0.801 . . . . 0.0 112.513 -173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.27 -17.1 65.7 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.48 -0.622 . . . . 0.0 114.062 -173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -159.06 95.02 1.24 Allowed 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.422 1.111 . . . . 0.0 110.106 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 50.41 25.88 2.09 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.731 0.812 . . . . 0.0 112.533 178.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 53.76 24.43 4.38 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.02 0.928 . . . . 0.0 112.633 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.76 -25.24 68.11 Favored 'General case' 0 N--CA 1.454 -0.257 0 O-C-N 121.82 -0.55 . . . . 0.0 111.196 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -73.57 -36.85 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -68.07 -42.07 80.96 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -66.05 -22.74 66.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.293 0.637 . . . . 0.0 111.749 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -77.45 -33.32 54.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.927 0.33 . . . . 0.0 110.571 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.1 -30.47 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.99 -31.93 71.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.688 0.28 . . . . 0.0 110.346 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -79.43 -25.13 42.07 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.255 0.622 . . . . 0.0 110.726 177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.89 -28.73 55.46 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.299 1.039 . . . . 0.0 111.53 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -129.05 7.65 5.53 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 56.9 17.43 3.3 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.046 0.938 . . . . 0.0 112.26 -176.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 24.6 p -91.98 -175.7 4.18 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.593 0.757 . . . . 0.0 110.324 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.8 t -132.09 145.17 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.5 mt -133.89 144.72 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 m -136.73 115.58 12.22 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.1 t -84.38 147.34 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.484 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -131.17 61.2 1.64 Allowed 'General case' 0 C--O 1.232 0.175 0 C-N-CA 123.03 0.532 . . . . 0.0 111.674 -175.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 p -61.32 -11.3 9.35 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -73.35 -17.49 61.29 Favored 'General case' 0 N--CA 1.456 -0.146 0 O-C-N 122.132 -0.355 . . . . 0.0 110.732 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.7 t -82.78 154.4 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.621 0.769 . . . . 0.0 111.591 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -147.97 129.8 15.22 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.9 t -140.58 167.91 21.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.94 0.496 . . . . 0.0 110.664 177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.3 t -62.62 -10.29 11.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.718 0.807 . . . . 0.0 111.466 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -65.97 -18.12 65.13 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.04 28.81 73.91 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.59 167.29 22.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 123.342 0.657 . . . . 0.0 111.493 -172.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.8 m -110.47 132.81 21.35 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.6 154.62 27.31 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.409 2.739 . . . . 0.0 110.963 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.5 t -138.45 147.43 25.42 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 124.337 1.055 . . . . 0.0 110.606 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -122.67 155.58 36.11 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.505 0.722 . . . . 0.0 110.808 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.7 mt -137.64 147.7 26.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 C-N-CA 123.642 0.777 . . . . 0.0 109.286 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 48.3 t -139.52 141.3 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 123.707 0.803 . . . . 0.0 110.124 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -161.63 167.13 25.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.338 0.655 . . . . 0.0 109.923 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -72.05 -19.15 61.88 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.207 -0.308 . . . . 0.0 111.541 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.1 p30 -155.26 162.63 40.85 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.838 0.455 . . . . 0.0 111.138 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.9 mtmm -75.13 -14.1 60.53 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 122.299 -0.251 . . . . 0.0 111.224 177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -67.24 -15.52 63.75 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 122.795 0.438 . . . . 0.0 110.937 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -123.48 -23.6 4.76 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 122.853 0.461 . . . . 0.0 111.176 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 11.1 t -73.05 -38.81 66.35 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -72.08 -28.94 63.64 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 122.485 -0.134 . . . . 0.0 111.328 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.04 58.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 175.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -68.97 -52.6 27.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.914 0.485 . . . . 0.0 110.267 176.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -69.02 -12.61 61.85 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.65 -35.12 34.32 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.915 -0.491 . . . . 0.0 111.152 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -83.32 -5.04 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 122.126 -0.359 . . . . 0.0 110.718 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.0 mmt -100.93 2.98 41.32 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 41.1 t -156.79 -29.43 0.09 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.2 mt -107.47 -46.45 3.84 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 118.411 0.55 . . . . 0.0 111.745 -176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 55.1 mtp 54.6 8.33 0.2 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.73 1.212 . . . . 0.0 112.722 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 51.36 15.98 0.37 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.833 1.253 . . . . 0.0 113.558 -174.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 31.7 t -156.11 8.59 0.23 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.698 0.399 . . . . 0.0 111.904 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -148.37 18.97 1.07 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.791 -0.568 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -69.75 -9.94 56.45 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.759 0.424 . . . . 0.0 111.409 -179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -76.58 2.27 14.45 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 117.371 -1.299 . . . . 0.0 109.836 179.554 . . . . . . . . 0 0 . 1 stop_ save_